Datasets:
Metadata v2.2: corrections from human review (non-human-animal terms, culture life stage, sex from sample text, 10 manual corrections)
Browse files- metadata/v2/README.md +25 -9
- metadata/v2/changes_v2.csv +24 -0
- metadata/v2/dropped_disease_terms.csv +348 -332
- metadata/v2/provenance.json +13 -12
- metadata/v2/qa_v2.json +22 -20
- metadata/v2/samples_metadata_v2.csv +0 -0
- metadata/v2/samples_metadata_v2.parquet +2 -2
- metadata/v2/schema_v2.json +1 -0
- metadata/v2/studies_v2.csv +7 -7
metadata/v2/README.md
CHANGED
|
@@ -1,6 +1,6 @@
|
|
| 1 |
# SpatialDataAgent-DB sample metadata v2
|
| 2 |
|
| 3 |
-
Schema `sda-sample-metadata-2`, version 2.
|
| 4 |
No expression, coordinate or image file changes; v2 is a new metadata table that sits next to the release.
|
| 5 |
|
| 6 |
## Files
|
|
@@ -11,27 +11,27 @@ No expression, coordinate or image file changes; v2 is a new metadata table that
|
|
| 11 |
| `samples_metadata_v2.csv` | the same table; lists joined with `;`, confidence as JSON |
|
| 12 |
| `studies_v2.csv` | one row per study (1,265): title, species, platforms, assays, organs, diseases, PubMed IDs, split |
|
| 13 |
| `schema_v2.json` | definition of every column |
|
| 14 |
-
| `changes_v2.csv` | every value that differs from a v3 column, with its basis (204 platform changes,
|
| 15 |
| `dropped_disease_terms.csv` | disease terms removed by the short-synonym filter (331) |
|
| 16 |
| `qa_v2.json` | counts and consistency-flag totals |
|
| 17 |
|
| 18 |
## What is new for users
|
| 19 |
|
| 20 |
- **Organ and tissue.** Each sample has an organ from a fixed list of 43 (a metastasis is placed at its site),
|
| 21 |
-
and 11,
|
| 22 |
-
- **Disease.** Each sample has a `disease_status`: disease 7,
|
| 23 |
"Perturbation" covers interventions that are not a named disease, such as a knockout without a disease name, a
|
| 24 |
-
drug, mechanical loading or regeneration. 6,
|
| 25 |
than one, for example IPMN with co-occurring PDAC. The control arm of a disease or tumour model counts as
|
| 26 |
disease, not normal.
|
| 27 |
- **Sample kind.** primary tissue 8,574, tumour tissue 2,754, metastasis 352, organoid 212, xenograft 185, whole
|
| 28 |
embryo/organism 57, cell culture 17, engineered tissue 10, unknown 2.
|
| 29 |
- **Donor.**
|
| 30 |
-
- `life_stage`: embryonic, fetal, neonatal or infant, juvenile, adult, aged, or not stated. 5,
|
| 31 |
-
stated stage. Where the age notation is unambiguous, the stage comes from a fixed age rule (3,
|
| 32 |
otherwise from the model. Rule for mouse and rat: neonatal up to P21, juvenile under 6 weeks, adult under
|
| 33 |
18 months, aged from 18 months. For human, ages in years or post-conception weeks.
|
| 34 |
-
- `sex`: male 2,
|
| 35 |
unknown.
|
| 36 |
- `donor_key` = `<study>:<donor>`, for donor-level splits (3,391 samples).
|
| 37 |
- **Species.**
|
|
@@ -109,7 +109,7 @@ the same source text, and every "wrong" verdict was then read by hand (Claude).
|
|
| 109 |
- Vagina and pleura are not in the organ list, so those samples are "other" or "lung".
|
| 110 |
- Disease abbreviations outside the curated list (e.g. "MN" for membranous nephropathy) give a disease status
|
| 111 |
without a MONDO term.
|
| 112 |
-
- `life_stage` is "not stated" for 7,
|
| 113 |
- 20 samples are flagged `normal_but_disease_text`: the raw disease field names a disease but the sample was
|
| 114 |
judged normal. Most are tissue adjacent to a tumour, which is correct; the rest are unclear.
|
| 115 |
|
|
@@ -125,6 +125,22 @@ repository:
|
|
| 125 |
|
| 126 |
## Versions
|
| 127 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 128 |
- **2.1** (tag `metadata-v2.1-20261105`): each assay now has one name (for example "Resolve Molecular Cartography"
|
| 129 |
became "Molecular Cartography", and "Visium (FFPE)" became "Visium", since preservation is its own field).
|
| 130 |
`um_per_unit` and `image_um_per_px` are copied exactly from the release parquet. Organ, tissue, disease, life stage and the other annotations did not change. One derived field did: `assay_type` of the 6 ISS (Cartana) samples of GSE227046 is now imaging-based (it was sequencing-based).
|
|
|
|
| 1 |
# SpatialDataAgent-DB sample metadata v2
|
| 2 |
|
| 3 |
+
Schema `sda-sample-metadata-2`, version 2.2 (2026-11-06), built from release v3 (`sda-unified-20261010-v3`, 12,163 samples).
|
| 4 |
No expression, coordinate or image file changes; v2 is a new metadata table that sits next to the release.
|
| 5 |
|
| 6 |
## Files
|
|
|
|
| 11 |
| `samples_metadata_v2.csv` | the same table; lists joined with `;`, confidence as JSON |
|
| 12 |
| `studies_v2.csv` | one row per study (1,265): title, species, platforms, assays, organs, diseases, PubMed IDs, split |
|
| 13 |
| `schema_v2.json` | definition of every column |
|
| 14 |
+
| `changes_v2.csv` | every value that differs from a v3 column, with its basis (204 platform changes, 32 manual corrections in 14 samples) |
|
| 15 |
| `dropped_disease_terms.csv` | disease terms removed by the short-synonym filter (331) |
|
| 16 |
| `qa_v2.json` | counts and consistency-flag totals |
|
| 17 |
|
| 18 |
## What is new for users
|
| 19 |
|
| 20 |
- **Organ and tissue.** Each sample has an organ from a fixed list of 43 (a metastasis is placed at its site),
|
| 21 |
+
and 11,605 samples (95%) have a UBERON tissue term (279 distinct terms). The GEO text stays in `tissue_raw`.
|
| 22 |
+
- **Disease.** Each sample has a `disease_status`: disease 7,023, normal 3,948, perturbation 1,125, not stated 67.
|
| 23 |
"Perturbation" covers interventions that are not a named disease, such as a knockout without a disease name, a
|
| 24 |
+
drug, mechanical loading or regeneration. 6,479 samples have MONDO terms (404 distinct); a sample can have more
|
| 25 |
than one, for example IPMN with co-occurring PDAC. The control arm of a disease or tumour model counts as
|
| 26 |
disease, not normal.
|
| 27 |
- **Sample kind.** primary tissue 8,574, tumour tissue 2,754, metastasis 352, organoid 212, xenograft 185, whole
|
| 28 |
embryo/organism 57, cell culture 17, engineered tissue 10, unknown 2.
|
| 29 |
- **Donor.**
|
| 30 |
+
- `life_stage`: embryonic, fetal, neonatal or infant, juvenile, adult, aged, or not stated. 5,103 samples have a
|
| 31 |
+
stated stage. Where the age notation is unambiguous, the stage comes from a fixed age rule (3,752 samples);
|
| 32 |
otherwise from the model. Rule for mouse and rat: neonatal up to P21, juvenile under 6 weeks, adult under
|
| 33 |
18 months, aged from 18 months. For human, ages in years or post-conception weeks.
|
| 34 |
+
- `sex`: male 2,689, female 2,012, mixed 21, unknown 7,441 (77 taken from the words male / female in the sample's own title or characteristics). Coded values without a key, such as 1/2, stay
|
| 35 |
unknown.
|
| 36 |
- `donor_key` = `<study>:<donor>`, for donor-level splits (3,391 samples).
|
| 37 |
- **Species.**
|
|
|
|
| 109 |
- Vagina and pleura are not in the organ list, so those samples are "other" or "lung".
|
| 110 |
- Disease abbreviations outside the curated list (e.g. "MN" for membranous nephropathy) give a disease status
|
| 111 |
without a MONDO term.
|
| 112 |
+
- `life_stage` is "not stated" for 7,060 samples: most GEO records give no age.
|
| 113 |
- 20 samples are flagged `normal_but_disease_text`: the raw disease field names a disease but the sample was
|
| 114 |
judged normal. Most are tissue adjacent to a tumour, which is correct; the rest are unclear.
|
| 115 |
|
|
|
|
| 125 |
|
| 126 |
## Versions
|
| 127 |
|
| 128 |
+
- **2.2** (tag `metadata-v2.2-20261106`): corrections from a human reader's review of the 200-sample pack.
|
| 129 |
+
- Rules applied to every sample:
|
| 130 |
+
- MONDO "..., non-human animal" terms are removed from human samples (16 samples).
|
| 131 |
+
- Organoids, cultures and engineered tissue get life stage "not stated", because culture time is not the donor's
|
| 132 |
+
age.
|
| 133 |
+
- Sex is read from the words male / female in the sample's own text when the extracted field is empty
|
| 134 |
+
(77 samples).
|
| 135 |
+
- Mouse and rat ages in days within an age series (e.g. "0d") are read as postnatal days.
|
| 136 |
+
- Manual corrections in 10 samples, each with its basis in `overrides_v2.csv`:
|
| 137 |
+
- actinic keratosis for the 5 GSE294844 samples (the series design says so; the sample records do not);
|
| 138 |
+
- "HD" read as healthy donor;
|
| 139 |
+
- a diverticular fistula read as diverticulitis, not IBD;
|
| 140 |
+
- Cre-only and wild-type controls set to normal;
|
| 141 |
+
- a graft with no stated site set to organ "other".
|
| 142 |
+
- New column `sex_source`.
|
| 143 |
+
|
| 144 |
- **2.1** (tag `metadata-v2.1-20261105`): each assay now has one name (for example "Resolve Molecular Cartography"
|
| 145 |
became "Molecular Cartography", and "Visium (FFPE)" became "Visium", since preservation is its own field).
|
| 146 |
`um_per_unit` and `image_um_per_px` are copied exactly from the release parquet. Organ, tissue, disease, life stage and the other annotations did not change. One derived field did: `assay_type` of the 6 ISS (Cartana) samples of GSE227046 is now imaging-based (it was sequencing-based).
|
metadata/v2/changes_v2.csv
CHANGED
|
@@ -211,3 +211,27 @@ GSM7412887,disease_ontology,,MONDO:0004975|Alzheimer disease,manual override (wa
|
|
| 211 |
GSM7412889,disease_ontology,,MONDO:0004975|Alzheimer disease,manual override (was []): as GSM7412887
|
| 212 |
GSM7412891,disease_ontology,,MONDO:0004975|Alzheimer disease,manual override (was []): as GSM7412887
|
| 213 |
GSM7412893,disease_ontology,,MONDO:0004975|Alzheimer disease,manual override (was []): as GSM7412887
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 211 |
GSM7412889,disease_ontology,,MONDO:0004975|Alzheimer disease,manual override (was []): as GSM7412887
|
| 212 |
GSM7412891,disease_ontology,,MONDO:0004975|Alzheimer disease,manual override (was []): as GSM7412887
|
| 213 |
GSM7412893,disease_ontology,,MONDO:0004975|Alzheimer disease,manual override (was []): as GSM7412887
|
| 214 |
+
GSM8925216,disease_status,,disease,manual override (was normal): GSE294844 overall design: 'Samples are human actinic keratoses specimens' (sample record says only 'skin')
|
| 215 |
+
GSM8925216,disease_ontology,,MONDO:0005173|actinic keratosis,manual override (was []): as above
|
| 216 |
+
GSM8925216,sample_kind,,primary tissue,"manual override (was primary tissue): AK is a pre-malignant lesion, kept as primary tissue"
|
| 217 |
+
GSM8925217,disease_status,,disease,manual override (was normal): GSE294844 overall design: 'Samples are human actinic keratoses specimens' (sample record says only 'skin')
|
| 218 |
+
GSM8925217,disease_ontology,,MONDO:0005173|actinic keratosis,manual override (was []): as above
|
| 219 |
+
GSM8925217,sample_kind,,primary tissue,"manual override (was primary tissue): AK is a pre-malignant lesion, kept as primary tissue"
|
| 220 |
+
GSM8925218,disease_status,,disease,manual override (was normal): GSE294844 overall design: 'Samples are human actinic keratoses specimens' (sample record says only 'skin')
|
| 221 |
+
GSM8925218,disease_ontology,,MONDO:0005173|actinic keratosis,manual override (was []): as above
|
| 222 |
+
GSM8925218,sample_kind,,primary tissue,"manual override (was primary tissue): AK is a pre-malignant lesion, kept as primary tissue"
|
| 223 |
+
GSM8925219,disease_status,,disease,manual override (was normal): GSE294844 overall design: 'Samples are human actinic keratoses specimens' (sample record says only 'skin')
|
| 224 |
+
GSM8925219,disease_ontology,,MONDO:0005173|actinic keratosis,manual override (was []): as above
|
| 225 |
+
GSM8925219,sample_kind,,primary tissue,"manual override (was primary tissue): AK is a pre-malignant lesion, kept as primary tissue"
|
| 226 |
+
GSM8925221,disease_status,,disease,manual override (was normal): GSE294844 overall design: 'Samples are human actinic keratoses specimens' (sample record says only 'skin')
|
| 227 |
+
GSM8925221,disease_ontology,,MONDO:0005173|actinic keratosis,manual override (was []): as above
|
| 228 |
+
GSM8925221,sample_kind,,primary tissue,"manual override (was primary tissue): AK is a pre-malignant lesion, kept as primary tissue"
|
| 229 |
+
GSM9769922,disease_status,,normal,"manual override (was disease): 'HD' (titles HD8HD9, HD31HD32) = healthy donor in this Stevens-Johnson study"
|
| 230 |
+
GSM9769922,disease_ontology,,,manual override (was ['MONDO:0018229']): healthy donor: no disease
|
| 231 |
+
GSM8674632,disease_ontology,,MONDO:0001674|diverticulitis of colon,"manual override (was ['MONDO:0005265']): fistula type DIVERTICULAR (a diverticular fistula, the comparison group of this Crohn's fistula study), not IBD"
|
| 232 |
+
GSM9429459,organ,,other,"manual override (was prostate): MyC-CaP cells inoculated into mice; the site is not stated, so by the graft rule the organ is other"
|
| 233 |
+
GSM9429459,tissue_ontology,,,manual override (was UBERON:0002367): graft site not stated
|
| 234 |
+
GSM9232561,disease_status,,normal,"manual override (was disease): genotype 'Cre' (Kras wt/wt, p48-cre): the Cre-only control of a hereditary pancreatitis model"
|
| 235 |
+
GSM9232561,disease_ontology,,,"manual override (was ['MONDO:0005003', 'MONDO:0003847']): Cre-only control"
|
| 236 |
+
GSM9802661,disease_status,,normal,manual override (was disease): title 'WT_4': wild-type control of a pulmonary hypertension study
|
| 237 |
+
GSM9802661,disease_ontology,,,manual override (was ['MONDO:0005149']): wild-type control
|
metadata/v2/dropped_disease_terms.csv
CHANGED
|
@@ -1,332 +1,348 @@
|
|
| 1 |
-
gsm,term,name
|
| 2 |
-
GSM3399307,MONDO:0000429,autosomal genetic disease
|
| 3 |
-
GSM3399308,MONDO:0000429,autosomal genetic disease
|
| 4 |
-
GSM3399309,MONDO:0000429,autosomal genetic disease
|
| 5 |
-
GSM3399310,MONDO:0000429,autosomal genetic disease
|
| 6 |
-
GSM3399311,MONDO:0000429,autosomal genetic disease
|
| 7 |
-
GSM3399312,MONDO:0000429,autosomal genetic disease
|
| 8 |
-
GSM3399324,MONDO:0000429,autosomal genetic disease
|
| 9 |
-
GSM3399325,MONDO:0000429,autosomal genetic disease
|
| 10 |
-
GSM3399327,MONDO:0000429,autosomal genetic disease
|
| 11 |
-
GSM3399328,MONDO:0000429,autosomal genetic disease
|
| 12 |
-
GSM3399329,MONDO:0000429,autosomal genetic disease
|
| 13 |
-
GSM3399330,MONDO:0000429,autosomal genetic disease
|
| 14 |
-
GSM3399331,MONDO:0000429,autosomal genetic disease
|
| 15 |
-
GSM3399332,MONDO:0000429,autosomal genetic disease
|
| 16 |
-
GSM3399333,MONDO:0000429,autosomal genetic disease
|
| 17 |
-
GSM3399335,MONDO:0000429,autosomal genetic disease
|
| 18 |
-
GSM3399336,MONDO:0000429,autosomal genetic disease
|
| 19 |
-
GSM3399338,MONDO:0000429,autosomal genetic disease
|
| 20 |
-
GSM3399339,MONDO:0000429,autosomal genetic disease
|
| 21 |
-
GSM3399340,MONDO:0000429,autosomal genetic disease
|
| 22 |
-
GSM3399341,MONDO:0000429,autosomal genetic disease
|
| 23 |
-
GSM3399342,MONDO:0000429,autosomal genetic disease
|
| 24 |
-
GSM3399343,MONDO:0000429,autosomal genetic disease
|
| 25 |
-
GSM3399344,MONDO:0000429,autosomal genetic disease
|
| 26 |
-
GSM3399345,MONDO:0000429,autosomal genetic disease
|
| 27 |
-
GSM3399346,MONDO:0000429,autosomal genetic disease
|
| 28 |
-
GSM3399347,MONDO:0000429,autosomal genetic disease
|
| 29 |
-
GSM3399348,MONDO:0000429,autosomal genetic disease
|
| 30 |
-
GSM3399349,MONDO:0000429,autosomal genetic disease
|
| 31 |
-
GSM3399350,MONDO:0000429,autosomal genetic disease
|
| 32 |
-
GSM3399351,MONDO:0000429,autosomal genetic disease
|
| 33 |
-
GSM3399352,MONDO:0000429,autosomal genetic disease
|
| 34 |
-
GSM3399354,MONDO:0000429,autosomal genetic disease
|
| 35 |
-
GSM3399355,MONDO:0000429,autosomal genetic disease
|
| 36 |
-
GSM3399356,MONDO:0000429,autosomal genetic disease
|
| 37 |
-
GSM3399356,MONDO:0002254,syndromic disease
|
| 38 |
-
GSM3399357,MONDO:0000429,autosomal genetic disease
|
| 39 |
-
GSM3399358,MONDO:0000429,autosomal genetic disease
|
| 40 |
-
GSM3399359,MONDO:0000429,autosomal genetic disease
|
| 41 |
-
GSM3399360,MONDO:0000429,autosomal genetic disease
|
| 42 |
-
GSM3399361,MONDO:0000429,autosomal genetic disease
|
| 43 |
-
GSM3399362,MONDO:0000429,autosomal genetic disease
|
| 44 |
-
GSM3399363,MONDO:0000429,autosomal genetic disease
|
| 45 |
-
GSM3399364,MONDO:0000429,autosomal genetic disease
|
| 46 |
-
GSM3399365,MONDO:0000429,autosomal genetic disease
|
| 47 |
-
GSM3399366,MONDO:0000429,autosomal genetic disease
|
| 48 |
-
GSM3399367,MONDO:0000429,autosomal genetic disease
|
| 49 |
-
GSM3399368,MONDO:0000429,autosomal genetic disease
|
| 50 |
-
GSM3399369,MONDO:0000429,autosomal genetic disease
|
| 51 |
-
GSM3399370,MONDO:0000429,autosomal genetic disease
|
| 52 |
-
GSM3399371,MONDO:0000429,autosomal genetic disease
|
| 53 |
-
GSM3399372,MONDO:0000429,autosomal genetic disease
|
| 54 |
-
GSM3399373,MONDO:0000429,autosomal genetic disease
|
| 55 |
-
GSM3399374,MONDO:0000429,autosomal genetic disease
|
| 56 |
-
GSM3399375,MONDO:0000429,autosomal genetic disease
|
| 57 |
-
GSM3399376,MONDO:0000429,autosomal genetic disease
|
| 58 |
-
GSM3399377,MONDO:0000429,autosomal genetic disease
|
| 59 |
-
GSM3399378,MONDO:0000429,autosomal genetic disease
|
| 60 |
-
GSM3399379,MONDO:0000429,autosomal genetic disease
|
| 61 |
-
GSM3399380,MONDO:0000429,autosomal genetic disease
|
| 62 |
-
GSM3399381,MONDO:0000429,autosomal genetic disease
|
| 63 |
-
GSM3399382,MONDO:0000429,autosomal genetic disease
|
| 64 |
-
GSM3399384,MONDO:0000429,autosomal genetic disease
|
| 65 |
-
GSM3399385,MONDO:0000429,autosomal genetic disease
|
| 66 |
-
GSM3399386,MONDO:0000429,autosomal genetic disease
|
| 67 |
-
GSM3399387,MONDO:0000429,autosomal genetic disease
|
| 68 |
-
GSM3399388,MONDO:0000429,autosomal genetic disease
|
| 69 |
-
GSM3399389,MONDO:0000429,autosomal genetic disease
|
| 70 |
-
GSM3399390,MONDO:0000429,autosomal genetic disease
|
| 71 |
-
GSM3399391,MONDO:0000429,autosomal genetic disease
|
| 72 |
-
GSM3399392,MONDO:0000429,autosomal genetic disease
|
| 73 |
-
GSM3399393,MONDO:0000429,autosomal genetic disease
|
| 74 |
-
GSM3399394,MONDO:0000429,autosomal genetic disease
|
| 75 |
-
GSM3399395,MONDO:0000429,autosomal genetic disease
|
| 76 |
-
GSM3399396,MONDO:0000429,autosomal genetic disease
|
| 77 |
-
GSM3399397,MONDO:0000429,autosomal genetic disease
|
| 78 |
-
GSM3399398,MONDO:0000429,autosomal genetic disease
|
| 79 |
-
GSM3399399,MONDO:0000429,autosomal genetic disease
|
| 80 |
-
GSM3399400,MONDO:0000429,autosomal genetic disease
|
| 81 |
-
GSM3399401,MONDO:0000429,autosomal genetic disease
|
| 82 |
-
GSM3399402,MONDO:0000429,autosomal genetic disease
|
| 83 |
-
GSM3399403,MONDO:0000429,autosomal genetic disease
|
| 84 |
-
GSM3399404,MONDO:0000429,autosomal genetic disease
|
| 85 |
-
GSM3399405,MONDO:0000429,autosomal genetic disease
|
| 86 |
-
GSM3399406,MONDO:0000429,autosomal genetic disease
|
| 87 |
-
GSM3399407,MONDO:0000429,autosomal genetic disease
|
| 88 |
-
GSM3399408,MONDO:0000429,autosomal genetic disease
|
| 89 |
-
GSM5538852,MONDO:0015974,severe combined immunodeficiency
|
| 90 |
-
GSM5538853,MONDO:0015974,severe combined immunodeficiency
|
| 91 |
-
GSM5538854,MONDO:0015974,severe combined immunodeficiency
|
| 92 |
-
GSM5538855,MONDO:0015974,severe combined immunodeficiency
|
| 93 |
-
GSM5713386,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 94 |
-
GSM5713387,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 95 |
-
GSM5713388,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 96 |
-
GSM5713389,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 97 |
-
GSM5713390,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 98 |
-
GSM5713396,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 99 |
-
GSM5713397,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 100 |
-
GSM5713398,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 101 |
-
GSM5713399,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 102 |
-
GSM5713400,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 103 |
-
GSM5713403,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 104 |
-
GSM5713404,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 105 |
-
GSM5713405,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 106 |
-
GSM5713406,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 107 |
-
GSM5713407,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 108 |
-
GSM5713408,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 109 |
-
GSM5713409,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 110 |
-
GSM5713410,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 111 |
-
GSM5713411,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 112 |
-
GSM5713412,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 113 |
-
GSM5713413,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 114 |
-
GSM5713414,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 115 |
-
GSM5713415,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 116 |
-
GSM5713416,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia
|
| 117 |
-
GSM6523977,MONDO:0100087,familial Alzheimer disease
|
| 118 |
-
GSM6613090,MONDO:0041656,ST-elevation myocardial infarction
|
| 119 |
-
GSM6631766,MONDO:0000425,X-linked disease
|
| 120 |
-
GSM7585149,MONDO:0005549,renal cell adenocarcinoma
|
| 121 |
-
GSM7585150,MONDO:0005549,renal cell adenocarcinoma
|
| 122 |
-
GSM7585151,MONDO:0005549,renal cell adenocarcinoma
|
| 123 |
-
GSM7585152,MONDO:0005549,renal cell adenocarcinoma
|
| 124 |
-
GSM7585153,MONDO:0005549,renal cell adenocarcinoma
|
| 125 |
-
GSM7585154,MONDO:0005549,renal cell adenocarcinoma
|
| 126 |
-
GSM7585155,MONDO:0005549,renal cell adenocarcinoma
|
| 127 |
-
GSM7585156,MONDO:0005549,renal cell adenocarcinoma
|
| 128 |
-
GSM7567492,MONDO:0015974,severe combined immunodeficiency
|
| 129 |
-
GSM7990552,MONDO:0019622,non-specific interstitial pneumonia
|
| 130 |
-
GSM7990553,MONDO:0019622,non-specific interstitial pneumonia
|
| 131 |
-
GSM8505462,MONDO:0017591,combined pulmonary fibrosis-emphysema syndrome
|
| 132 |
-
GSM7990295,MONDO:0005093,skin disorder
|
| 133 |
-
GSM8021238,MONDO:0005091,severe acute respiratory syndrome
|
| 134 |
-
GSM8021239,MONDO:0005091,severe acute respiratory syndrome
|
| 135 |
-
GSM8021240,MONDO:0005087,respiratory system disorder
|
| 136 |
-
GSM8021241,MONDO:0005087,respiratory system disorder
|
| 137 |
-
GSM8021241,MONDO:0020683,acute disease
|
| 138 |
-
GSM8021242,MONDO:0005091,severe acute respiratory syndrome
|
| 139 |
-
GSM8021243,MONDO:0005087,respiratory system disorder
|
| 140 |
-
GSM8021243,MONDO:0020683,acute disease
|
| 141 |
-
GSM8021244,MONDO:0005091,severe acute respiratory syndrome
|
| 142 |
-
GSM8021245,MONDO:0005091,severe acute respiratory syndrome
|
| 143 |
-
GSM8021246,MONDO:0005091,severe acute respiratory syndrome
|
| 144 |
-
GSM8021247,MONDO:0005091,severe acute respiratory syndrome
|
| 145 |
-
GSM8021248,MONDO:0005087,respiratory system disorder
|
| 146 |
-
GSM8021249,MONDO:0005091,severe acute respiratory syndrome
|
| 147 |
-
GSM8021250,MONDO:0005091,severe acute respiratory syndrome
|
| 148 |
-
GSM8021251,MONDO:0005091,severe acute respiratory syndrome
|
| 149 |
-
GSM8021252,MONDO:0005087,respiratory system disorder
|
| 150 |
-
GSM8021253,MONDO:0005091,severe acute respiratory syndrome
|
| 151 |
-
GSM8021254,MONDO:0005087,respiratory system disorder
|
| 152 |
-
GSM8021255,MONDO:0005091,severe acute respiratory syndrome
|
| 153 |
-
GSM8021256,MONDO:0005091,severe acute respiratory syndrome
|
| 154 |
-
GSM8021257,MONDO:0005087,respiratory system disorder
|
| 155 |
-
GSM8021258,MONDO:0005091,severe acute respiratory syndrome
|
| 156 |
-
GSM8021259,MONDO:0005091,severe acute respiratory syndrome
|
| 157 |
-
GSM8021260,MONDO:0005087,respiratory system disorder
|
| 158 |
-
GSM8021261,MONDO:0005091,severe acute respiratory syndrome
|
| 159 |
-
GSM8021262,MONDO:0005091,severe acute respiratory syndrome
|
| 160 |
-
GSM8021263,MONDO:0005091,severe acute respiratory syndrome
|
| 161 |
-
GSM8021264,MONDO:0005091,severe acute respiratory syndrome
|
| 162 |
-
GSM8021265,MONDO:0005091,severe acute respiratory syndrome
|
| 163 |
-
GSM8021266,MONDO:0005091,severe acute respiratory syndrome
|
| 164 |
-
GSM8021267,MONDO:0005091,severe acute respiratory syndrome
|
| 165 |
-
GSM8021268,MONDO:0005091,severe acute respiratory syndrome
|
| 166 |
-
GSM8021269,MONDO:0005091,severe acute respiratory syndrome
|
| 167 |
-
GSM8021270,MONDO:0005091,severe acute respiratory syndrome
|
| 168 |
-
GSM8021271,MONDO:0005091,severe acute respiratory syndrome
|
| 169 |
-
GSM8021272,MONDO:0005087,respiratory system disorder
|
| 170 |
-
GSM8021272,MONDO:0020683,acute disease
|
| 171 |
-
GSM8021273,MONDO:0005091,severe acute respiratory syndrome
|
| 172 |
-
GSM8021274,MONDO:0005091,severe acute respiratory syndrome
|
| 173 |
-
GSM8021275,MONDO:0005087,respiratory system disorder
|
| 174 |
-
GSM8021276,MONDO:0005091,severe acute respiratory syndrome
|
| 175 |
-
GSM8021277,MONDO:0005091,severe acute respiratory syndrome
|
| 176 |
-
GSM8021278,MONDO:0005091,severe acute respiratory syndrome
|
| 177 |
-
GSM8021279,MONDO:0005087,respiratory system disorder
|
| 178 |
-
GSM8021279,MONDO:0020683,acute disease
|
| 179 |
-
GSM8021280,MONDO:0005091,severe acute respiratory syndrome
|
| 180 |
-
GSM8021281,MONDO:0005087,respiratory system disorder
|
| 181 |
-
GSM8021282,MONDO:0005087,respiratory system disorder
|
| 182 |
-
GSM8021283,MONDO:0005091,severe acute respiratory syndrome
|
| 183 |
-
GSM8021284,MONDO:0005091,severe acute respiratory syndrome
|
| 184 |
-
GSM8021285,MONDO:0005091,severe acute respiratory syndrome
|
| 185 |
-
GSM8021286,MONDO:0005091,severe acute respiratory syndrome
|
| 186 |
-
GSM8021287,MONDO:0005091,severe acute respiratory syndrome
|
| 187 |
-
GSM8021288,MONDO:0005087,respiratory system disorder
|
| 188 |
-
GSM8021288,MONDO:0020683,acute disease
|
| 189 |
-
GSM8021289,MONDO:0005087,respiratory system disorder
|
| 190 |
-
GSM8021290,MONDO:0005091,severe acute respiratory syndrome
|
| 191 |
-
GSM8021291,MONDO:0005091,severe acute respiratory syndrome
|
| 192 |
-
GSM8021292,MONDO:0005091,severe acute respiratory syndrome
|
| 193 |
-
GSM8021293,MONDO:0005091,severe acute respiratory syndrome
|
| 194 |
-
GSM8021294,MONDO:0005091,severe acute respiratory syndrome
|
| 195 |
-
GSM8021295,MONDO:0005091,severe acute respiratory syndrome
|
| 196 |
-
GSM8021296,MONDO:0005091,severe acute respiratory syndrome
|
| 197 |
-
GSM8021297,MONDO:0005091,severe acute respiratory syndrome
|
| 198 |
-
GSM8021298,MONDO:0005091,severe acute respiratory syndrome
|
| 199 |
-
GSM8021299,MONDO:0005091,severe acute respiratory syndrome
|
| 200 |
-
GSM8021300,MONDO:0005091,severe acute respiratory syndrome
|
| 201 |
-
GSM8021301,MONDO:0005091,severe acute respiratory syndrome
|
| 202 |
-
GSM8021302,MONDO:0005091,severe acute respiratory syndrome
|
| 203 |
-
GSM8021303,MONDO:0005091,severe acute respiratory syndrome
|
| 204 |
-
GSM8021304,MONDO:0005091,severe acute respiratory syndrome
|
| 205 |
-
GSM8021305,MONDO:0005091,severe acute respiratory syndrome
|
| 206 |
-
GSM8021306,MONDO:0005091,severe acute respiratory syndrome
|
| 207 |
-
GSM8021307,MONDO:0005087,respiratory system disorder
|
| 208 |
-
GSM8021307,MONDO:0020683,acute disease
|
| 209 |
-
GSM8021308,MONDO:0005091,severe acute respiratory syndrome
|
| 210 |
-
GSM8021309,MONDO:0005087,respiratory system disorder
|
| 211 |
-
GSM8021309,MONDO:0020683,acute disease
|
| 212 |
-
GSM8021310,MONDO:0005091,severe acute respiratory syndrome
|
| 213 |
-
GSM8021311,MONDO:0005091,severe acute respiratory syndrome
|
| 214 |
-
GSM8021312,MONDO:0005091,severe acute respiratory syndrome
|
| 215 |
-
GSM8021313,MONDO:0005091,severe acute respiratory syndrome
|
| 216 |
-
GSM8021314,MONDO:0005091,severe acute respiratory syndrome
|
| 217 |
-
GSM8021315,MONDO:0005091,severe acute respiratory syndrome
|
| 218 |
-
GSM8021316,MONDO:0005091,severe acute respiratory syndrome
|
| 219 |
-
GSM8021317,MONDO:0005091,severe acute respiratory syndrome
|
| 220 |
-
GSM8021318,MONDO:0005087,respiratory system disorder
|
| 221 |
-
GSM8021319,MONDO:0005087,respiratory system disorder
|
| 222 |
-
GSM8021320,MONDO:0005087,respiratory system disorder
|
| 223 |
-
GSM8021320,MONDO:0020683,acute disease
|
| 224 |
-
GSM8021321,MONDO:0005091,severe acute respiratory syndrome
|
| 225 |
-
GSM8021322,MONDO:0005091,severe acute respiratory syndrome
|
| 226 |
-
GSM8021323,MONDO:0005091,severe acute respiratory syndrome
|
| 227 |
-
GSM8021324,MONDO:0005091,severe acute respiratory syndrome
|
| 228 |
-
GSM8021325,MONDO:0005091,severe acute respiratory syndrome
|
| 229 |
-
GSM8021326,MONDO:0005091,severe acute respiratory syndrome
|
| 230 |
-
GSM8021327,MONDO:0005091,severe acute respiratory syndrome
|
| 231 |
-
GSM8021328,MONDO:0005087,respiratory system disorder
|
| 232 |
-
GSM8021329,MONDO:0005087,respiratory system disorder
|
| 233 |
-
GSM8021329,MONDO:0020683,acute disease
|
| 234 |
-
GSM8021330,MONDO:0005091,severe acute respiratory syndrome
|
| 235 |
-
GSM8021331,MONDO:0005091,severe acute respiratory syndrome
|
| 236 |
-
GSM8021332,MONDO:0005091,severe acute respiratory syndrome
|
| 237 |
-
GSM8021333,MONDO:0005091,severe acute respiratory syndrome
|
| 238 |
-
GSM8021334,MONDO:0005091,severe acute respiratory syndrome
|
| 239 |
-
GSM8021335,MONDO:0005091,severe acute respiratory syndrome
|
| 240 |
-
GSM8021336,MONDO:0005091,severe acute respiratory syndrome
|
| 241 |
-
GSM8021337,MONDO:0005091,severe acute respiratory syndrome
|
| 242 |
-
GSM8021338,MONDO:0005091,severe acute respiratory syndrome
|
| 243 |
-
GSM8021339,MONDO:0005091,severe acute respiratory syndrome
|
| 244 |
-
GSM8021340,MONDO:0005091,severe acute respiratory syndrome
|
| 245 |
-
GSM8021341,MONDO:0005091,severe acute respiratory syndrome
|
| 246 |
-
GSM8021342,MONDO:0005091,severe acute respiratory syndrome
|
| 247 |
-
GSM8021343,MONDO:0005091,severe acute respiratory syndrome
|
| 248 |
-
GSM8021344,MONDO:0005091,severe acute respiratory syndrome
|
| 249 |
-
GSM8021345,MONDO:0005091,severe acute respiratory syndrome
|
| 250 |
-
GSM8021346,MONDO:0005091,severe acute respiratory syndrome
|
| 251 |
-
GSM8021347,MONDO:0005091,severe acute respiratory syndrome
|
| 252 |
-
GSM8021348,MONDO:0005091,severe acute respiratory syndrome
|
| 253 |
-
GSM8021349,MONDO:0005091,severe acute respiratory syndrome
|
| 254 |
-
GSM8021350,MONDO:0005091,severe acute respiratory syndrome
|
| 255 |
-
GSM8021351,MONDO:0005091,severe acute respiratory syndrome
|
| 256 |
-
GSM8021352,MONDO:0005091,severe acute respiratory syndrome
|
| 257 |
-
GSM8021353,MONDO:0005091,severe acute respiratory syndrome
|
| 258 |
-
GSM8199179,MONDO:0015547,hereditary dementia
|
| 259 |
-
GSM8199179,MONDO:0024237,inherited neurodegenerative disorder
|
| 260 |
-
GSM8199180,MONDO:0015547,hereditary dementia
|
| 261 |
-
GSM8199180,MONDO:0024237,inherited neurodegenerative disorder
|
| 262 |
-
GSM8199188,MONDO:0100087,familial Alzheimer disease
|
| 263 |
-
GSM8199189,MONDO:0011743,Alzheimer disease 4
|
| 264 |
-
GSM8200276,MONDO:0006412,sinus histiocytosis with massive lymphadenopathy
|
| 265 |
-
|
| 266 |
-
|
| 267 |
-
|
| 268 |
-
|
| 269 |
-
|
| 270 |
-
|
| 271 |
-
|
| 272 |
-
|
| 273 |
-
|
| 274 |
-
|
| 275 |
-
|
| 276 |
-
|
| 277 |
-
|
| 278 |
-
|
| 279 |
-
|
| 280 |
-
|
| 281 |
-
|
| 282 |
-
|
| 283 |
-
|
| 284 |
-
|
| 285 |
-
|
| 286 |
-
|
| 287 |
-
|
| 288 |
-
|
| 289 |
-
|
| 290 |
-
|
| 291 |
-
|
| 292 |
-
|
| 293 |
-
|
| 294 |
-
|
| 295 |
-
|
| 296 |
-
|
| 297 |
-
|
| 298 |
-
|
| 299 |
-
|
| 300 |
-
|
| 301 |
-
|
| 302 |
-
|
| 303 |
-
|
| 304 |
-
|
| 305 |
-
|
| 306 |
-
|
| 307 |
-
|
| 308 |
-
|
| 309 |
-
|
| 310 |
-
|
| 311 |
-
|
| 312 |
-
|
| 313 |
-
|
| 314 |
-
|
| 315 |
-
|
| 316 |
-
|
| 317 |
-
|
| 318 |
-
|
| 319 |
-
|
| 320 |
-
|
| 321 |
-
|
| 322 |
-
|
| 323 |
-
|
| 324 |
-
|
| 325 |
-
|
| 326 |
-
|
| 327 |
-
|
| 328 |
-
|
| 329 |
-
|
| 330 |
-
|
| 331 |
-
|
| 332 |
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
gsm,term,name,reason
|
| 2 |
+
GSM3399307,MONDO:0000429,autosomal genetic disease,
|
| 3 |
+
GSM3399308,MONDO:0000429,autosomal genetic disease,
|
| 4 |
+
GSM3399309,MONDO:0000429,autosomal genetic disease,
|
| 5 |
+
GSM3399310,MONDO:0000429,autosomal genetic disease,
|
| 6 |
+
GSM3399311,MONDO:0000429,autosomal genetic disease,
|
| 7 |
+
GSM3399312,MONDO:0000429,autosomal genetic disease,
|
| 8 |
+
GSM3399324,MONDO:0000429,autosomal genetic disease,
|
| 9 |
+
GSM3399325,MONDO:0000429,autosomal genetic disease,
|
| 10 |
+
GSM3399327,MONDO:0000429,autosomal genetic disease,
|
| 11 |
+
GSM3399328,MONDO:0000429,autosomal genetic disease,
|
| 12 |
+
GSM3399329,MONDO:0000429,autosomal genetic disease,
|
| 13 |
+
GSM3399330,MONDO:0000429,autosomal genetic disease,
|
| 14 |
+
GSM3399331,MONDO:0000429,autosomal genetic disease,
|
| 15 |
+
GSM3399332,MONDO:0000429,autosomal genetic disease,
|
| 16 |
+
GSM3399333,MONDO:0000429,autosomal genetic disease,
|
| 17 |
+
GSM3399335,MONDO:0000429,autosomal genetic disease,
|
| 18 |
+
GSM3399336,MONDO:0000429,autosomal genetic disease,
|
| 19 |
+
GSM3399338,MONDO:0000429,autosomal genetic disease,
|
| 20 |
+
GSM3399339,MONDO:0000429,autosomal genetic disease,
|
| 21 |
+
GSM3399340,MONDO:0000429,autosomal genetic disease,
|
| 22 |
+
GSM3399341,MONDO:0000429,autosomal genetic disease,
|
| 23 |
+
GSM3399342,MONDO:0000429,autosomal genetic disease,
|
| 24 |
+
GSM3399343,MONDO:0000429,autosomal genetic disease,
|
| 25 |
+
GSM3399344,MONDO:0000429,autosomal genetic disease,
|
| 26 |
+
GSM3399345,MONDO:0000429,autosomal genetic disease,
|
| 27 |
+
GSM3399346,MONDO:0000429,autosomal genetic disease,
|
| 28 |
+
GSM3399347,MONDO:0000429,autosomal genetic disease,
|
| 29 |
+
GSM3399348,MONDO:0000429,autosomal genetic disease,
|
| 30 |
+
GSM3399349,MONDO:0000429,autosomal genetic disease,
|
| 31 |
+
GSM3399350,MONDO:0000429,autosomal genetic disease,
|
| 32 |
+
GSM3399351,MONDO:0000429,autosomal genetic disease,
|
| 33 |
+
GSM3399352,MONDO:0000429,autosomal genetic disease,
|
| 34 |
+
GSM3399354,MONDO:0000429,autosomal genetic disease,
|
| 35 |
+
GSM3399355,MONDO:0000429,autosomal genetic disease,
|
| 36 |
+
GSM3399356,MONDO:0000429,autosomal genetic disease,
|
| 37 |
+
GSM3399356,MONDO:0002254,syndromic disease,
|
| 38 |
+
GSM3399357,MONDO:0000429,autosomal genetic disease,
|
| 39 |
+
GSM3399358,MONDO:0000429,autosomal genetic disease,
|
| 40 |
+
GSM3399359,MONDO:0000429,autosomal genetic disease,
|
| 41 |
+
GSM3399360,MONDO:0000429,autosomal genetic disease,
|
| 42 |
+
GSM3399361,MONDO:0000429,autosomal genetic disease,
|
| 43 |
+
GSM3399362,MONDO:0000429,autosomal genetic disease,
|
| 44 |
+
GSM3399363,MONDO:0000429,autosomal genetic disease,
|
| 45 |
+
GSM3399364,MONDO:0000429,autosomal genetic disease,
|
| 46 |
+
GSM3399365,MONDO:0000429,autosomal genetic disease,
|
| 47 |
+
GSM3399366,MONDO:0000429,autosomal genetic disease,
|
| 48 |
+
GSM3399367,MONDO:0000429,autosomal genetic disease,
|
| 49 |
+
GSM3399368,MONDO:0000429,autosomal genetic disease,
|
| 50 |
+
GSM3399369,MONDO:0000429,autosomal genetic disease,
|
| 51 |
+
GSM3399370,MONDO:0000429,autosomal genetic disease,
|
| 52 |
+
GSM3399371,MONDO:0000429,autosomal genetic disease,
|
| 53 |
+
GSM3399372,MONDO:0000429,autosomal genetic disease,
|
| 54 |
+
GSM3399373,MONDO:0000429,autosomal genetic disease,
|
| 55 |
+
GSM3399374,MONDO:0000429,autosomal genetic disease,
|
| 56 |
+
GSM3399375,MONDO:0000429,autosomal genetic disease,
|
| 57 |
+
GSM3399376,MONDO:0000429,autosomal genetic disease,
|
| 58 |
+
GSM3399377,MONDO:0000429,autosomal genetic disease,
|
| 59 |
+
GSM3399378,MONDO:0000429,autosomal genetic disease,
|
| 60 |
+
GSM3399379,MONDO:0000429,autosomal genetic disease,
|
| 61 |
+
GSM3399380,MONDO:0000429,autosomal genetic disease,
|
| 62 |
+
GSM3399381,MONDO:0000429,autosomal genetic disease,
|
| 63 |
+
GSM3399382,MONDO:0000429,autosomal genetic disease,
|
| 64 |
+
GSM3399384,MONDO:0000429,autosomal genetic disease,
|
| 65 |
+
GSM3399385,MONDO:0000429,autosomal genetic disease,
|
| 66 |
+
GSM3399386,MONDO:0000429,autosomal genetic disease,
|
| 67 |
+
GSM3399387,MONDO:0000429,autosomal genetic disease,
|
| 68 |
+
GSM3399388,MONDO:0000429,autosomal genetic disease,
|
| 69 |
+
GSM3399389,MONDO:0000429,autosomal genetic disease,
|
| 70 |
+
GSM3399390,MONDO:0000429,autosomal genetic disease,
|
| 71 |
+
GSM3399391,MONDO:0000429,autosomal genetic disease,
|
| 72 |
+
GSM3399392,MONDO:0000429,autosomal genetic disease,
|
| 73 |
+
GSM3399393,MONDO:0000429,autosomal genetic disease,
|
| 74 |
+
GSM3399394,MONDO:0000429,autosomal genetic disease,
|
| 75 |
+
GSM3399395,MONDO:0000429,autosomal genetic disease,
|
| 76 |
+
GSM3399396,MONDO:0000429,autosomal genetic disease,
|
| 77 |
+
GSM3399397,MONDO:0000429,autosomal genetic disease,
|
| 78 |
+
GSM3399398,MONDO:0000429,autosomal genetic disease,
|
| 79 |
+
GSM3399399,MONDO:0000429,autosomal genetic disease,
|
| 80 |
+
GSM3399400,MONDO:0000429,autosomal genetic disease,
|
| 81 |
+
GSM3399401,MONDO:0000429,autosomal genetic disease,
|
| 82 |
+
GSM3399402,MONDO:0000429,autosomal genetic disease,
|
| 83 |
+
GSM3399403,MONDO:0000429,autosomal genetic disease,
|
| 84 |
+
GSM3399404,MONDO:0000429,autosomal genetic disease,
|
| 85 |
+
GSM3399405,MONDO:0000429,autosomal genetic disease,
|
| 86 |
+
GSM3399406,MONDO:0000429,autosomal genetic disease,
|
| 87 |
+
GSM3399407,MONDO:0000429,autosomal genetic disease,
|
| 88 |
+
GSM3399408,MONDO:0000429,autosomal genetic disease,
|
| 89 |
+
GSM5538852,MONDO:0015974,severe combined immunodeficiency,
|
| 90 |
+
GSM5538853,MONDO:0015974,severe combined immunodeficiency,
|
| 91 |
+
GSM5538854,MONDO:0015974,severe combined immunodeficiency,
|
| 92 |
+
GSM5538855,MONDO:0015974,severe combined immunodeficiency,
|
| 93 |
+
GSM5713386,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 94 |
+
GSM5713387,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 95 |
+
GSM5713388,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 96 |
+
GSM5713389,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 97 |
+
GSM5713390,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 98 |
+
GSM5713396,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 99 |
+
GSM5713397,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 100 |
+
GSM5713398,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 101 |
+
GSM5713399,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 102 |
+
GSM5713400,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 103 |
+
GSM5713403,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 104 |
+
GSM5713404,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 105 |
+
GSM5713405,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 106 |
+
GSM5713406,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 107 |
+
GSM5713407,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 108 |
+
GSM5713408,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 109 |
+
GSM5713409,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 110 |
+
GSM5713410,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 111 |
+
GSM5713411,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 112 |
+
GSM5713412,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 113 |
+
GSM5713413,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 114 |
+
GSM5713414,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 115 |
+
GSM5713415,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 116 |
+
GSM5713416,MONDO:0008264,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,
|
| 117 |
+
GSM6523977,MONDO:0100087,familial Alzheimer disease,
|
| 118 |
+
GSM6613090,MONDO:0041656,ST-elevation myocardial infarction,
|
| 119 |
+
GSM6631766,MONDO:0000425,X-linked disease,
|
| 120 |
+
GSM7585149,MONDO:0005549,renal cell adenocarcinoma,
|
| 121 |
+
GSM7585150,MONDO:0005549,renal cell adenocarcinoma,
|
| 122 |
+
GSM7585151,MONDO:0005549,renal cell adenocarcinoma,
|
| 123 |
+
GSM7585152,MONDO:0005549,renal cell adenocarcinoma,
|
| 124 |
+
GSM7585153,MONDO:0005549,renal cell adenocarcinoma,
|
| 125 |
+
GSM7585154,MONDO:0005549,renal cell adenocarcinoma,
|
| 126 |
+
GSM7585155,MONDO:0005549,renal cell adenocarcinoma,
|
| 127 |
+
GSM7585156,MONDO:0005549,renal cell adenocarcinoma,
|
| 128 |
+
GSM7567492,MONDO:0015974,severe combined immunodeficiency,
|
| 129 |
+
GSM7990552,MONDO:0019622,non-specific interstitial pneumonia,
|
| 130 |
+
GSM7990553,MONDO:0019622,non-specific interstitial pneumonia,
|
| 131 |
+
GSM8505462,MONDO:0017591,combined pulmonary fibrosis-emphysema syndrome,
|
| 132 |
+
GSM7990295,MONDO:0005093,skin disorder,
|
| 133 |
+
GSM8021238,MONDO:0005091,severe acute respiratory syndrome,
|
| 134 |
+
GSM8021239,MONDO:0005091,severe acute respiratory syndrome,
|
| 135 |
+
GSM8021240,MONDO:0005087,respiratory system disorder,
|
| 136 |
+
GSM8021241,MONDO:0005087,respiratory system disorder,
|
| 137 |
+
GSM8021241,MONDO:0020683,acute disease,
|
| 138 |
+
GSM8021242,MONDO:0005091,severe acute respiratory syndrome,
|
| 139 |
+
GSM8021243,MONDO:0005087,respiratory system disorder,
|
| 140 |
+
GSM8021243,MONDO:0020683,acute disease,
|
| 141 |
+
GSM8021244,MONDO:0005091,severe acute respiratory syndrome,
|
| 142 |
+
GSM8021245,MONDO:0005091,severe acute respiratory syndrome,
|
| 143 |
+
GSM8021246,MONDO:0005091,severe acute respiratory syndrome,
|
| 144 |
+
GSM8021247,MONDO:0005091,severe acute respiratory syndrome,
|
| 145 |
+
GSM8021248,MONDO:0005087,respiratory system disorder,
|
| 146 |
+
GSM8021249,MONDO:0005091,severe acute respiratory syndrome,
|
| 147 |
+
GSM8021250,MONDO:0005091,severe acute respiratory syndrome,
|
| 148 |
+
GSM8021251,MONDO:0005091,severe acute respiratory syndrome,
|
| 149 |
+
GSM8021252,MONDO:0005087,respiratory system disorder,
|
| 150 |
+
GSM8021253,MONDO:0005091,severe acute respiratory syndrome,
|
| 151 |
+
GSM8021254,MONDO:0005087,respiratory system disorder,
|
| 152 |
+
GSM8021255,MONDO:0005091,severe acute respiratory syndrome,
|
| 153 |
+
GSM8021256,MONDO:0005091,severe acute respiratory syndrome,
|
| 154 |
+
GSM8021257,MONDO:0005087,respiratory system disorder,
|
| 155 |
+
GSM8021258,MONDO:0005091,severe acute respiratory syndrome,
|
| 156 |
+
GSM8021259,MONDO:0005091,severe acute respiratory syndrome,
|
| 157 |
+
GSM8021260,MONDO:0005087,respiratory system disorder,
|
| 158 |
+
GSM8021261,MONDO:0005091,severe acute respiratory syndrome,
|
| 159 |
+
GSM8021262,MONDO:0005091,severe acute respiratory syndrome,
|
| 160 |
+
GSM8021263,MONDO:0005091,severe acute respiratory syndrome,
|
| 161 |
+
GSM8021264,MONDO:0005091,severe acute respiratory syndrome,
|
| 162 |
+
GSM8021265,MONDO:0005091,severe acute respiratory syndrome,
|
| 163 |
+
GSM8021266,MONDO:0005091,severe acute respiratory syndrome,
|
| 164 |
+
GSM8021267,MONDO:0005091,severe acute respiratory syndrome,
|
| 165 |
+
GSM8021268,MONDO:0005091,severe acute respiratory syndrome,
|
| 166 |
+
GSM8021269,MONDO:0005091,severe acute respiratory syndrome,
|
| 167 |
+
GSM8021270,MONDO:0005091,severe acute respiratory syndrome,
|
| 168 |
+
GSM8021271,MONDO:0005091,severe acute respiratory syndrome,
|
| 169 |
+
GSM8021272,MONDO:0005087,respiratory system disorder,
|
| 170 |
+
GSM8021272,MONDO:0020683,acute disease,
|
| 171 |
+
GSM8021273,MONDO:0005091,severe acute respiratory syndrome,
|
| 172 |
+
GSM8021274,MONDO:0005091,severe acute respiratory syndrome,
|
| 173 |
+
GSM8021275,MONDO:0005087,respiratory system disorder,
|
| 174 |
+
GSM8021276,MONDO:0005091,severe acute respiratory syndrome,
|
| 175 |
+
GSM8021277,MONDO:0005091,severe acute respiratory syndrome,
|
| 176 |
+
GSM8021278,MONDO:0005091,severe acute respiratory syndrome,
|
| 177 |
+
GSM8021279,MONDO:0005087,respiratory system disorder,
|
| 178 |
+
GSM8021279,MONDO:0020683,acute disease,
|
| 179 |
+
GSM8021280,MONDO:0005091,severe acute respiratory syndrome,
|
| 180 |
+
GSM8021281,MONDO:0005087,respiratory system disorder,
|
| 181 |
+
GSM8021282,MONDO:0005087,respiratory system disorder,
|
| 182 |
+
GSM8021283,MONDO:0005091,severe acute respiratory syndrome,
|
| 183 |
+
GSM8021284,MONDO:0005091,severe acute respiratory syndrome,
|
| 184 |
+
GSM8021285,MONDO:0005091,severe acute respiratory syndrome,
|
| 185 |
+
GSM8021286,MONDO:0005091,severe acute respiratory syndrome,
|
| 186 |
+
GSM8021287,MONDO:0005091,severe acute respiratory syndrome,
|
| 187 |
+
GSM8021288,MONDO:0005087,respiratory system disorder,
|
| 188 |
+
GSM8021288,MONDO:0020683,acute disease,
|
| 189 |
+
GSM8021289,MONDO:0005087,respiratory system disorder,
|
| 190 |
+
GSM8021290,MONDO:0005091,severe acute respiratory syndrome,
|
| 191 |
+
GSM8021291,MONDO:0005091,severe acute respiratory syndrome,
|
| 192 |
+
GSM8021292,MONDO:0005091,severe acute respiratory syndrome,
|
| 193 |
+
GSM8021293,MONDO:0005091,severe acute respiratory syndrome,
|
| 194 |
+
GSM8021294,MONDO:0005091,severe acute respiratory syndrome,
|
| 195 |
+
GSM8021295,MONDO:0005091,severe acute respiratory syndrome,
|
| 196 |
+
GSM8021296,MONDO:0005091,severe acute respiratory syndrome,
|
| 197 |
+
GSM8021297,MONDO:0005091,severe acute respiratory syndrome,
|
| 198 |
+
GSM8021298,MONDO:0005091,severe acute respiratory syndrome,
|
| 199 |
+
GSM8021299,MONDO:0005091,severe acute respiratory syndrome,
|
| 200 |
+
GSM8021300,MONDO:0005091,severe acute respiratory syndrome,
|
| 201 |
+
GSM8021301,MONDO:0005091,severe acute respiratory syndrome,
|
| 202 |
+
GSM8021302,MONDO:0005091,severe acute respiratory syndrome,
|
| 203 |
+
GSM8021303,MONDO:0005091,severe acute respiratory syndrome,
|
| 204 |
+
GSM8021304,MONDO:0005091,severe acute respiratory syndrome,
|
| 205 |
+
GSM8021305,MONDO:0005091,severe acute respiratory syndrome,
|
| 206 |
+
GSM8021306,MONDO:0005091,severe acute respiratory syndrome,
|
| 207 |
+
GSM8021307,MONDO:0005087,respiratory system disorder,
|
| 208 |
+
GSM8021307,MONDO:0020683,acute disease,
|
| 209 |
+
GSM8021308,MONDO:0005091,severe acute respiratory syndrome,
|
| 210 |
+
GSM8021309,MONDO:0005087,respiratory system disorder,
|
| 211 |
+
GSM8021309,MONDO:0020683,acute disease,
|
| 212 |
+
GSM8021310,MONDO:0005091,severe acute respiratory syndrome,
|
| 213 |
+
GSM8021311,MONDO:0005091,severe acute respiratory syndrome,
|
| 214 |
+
GSM8021312,MONDO:0005091,severe acute respiratory syndrome,
|
| 215 |
+
GSM8021313,MONDO:0005091,severe acute respiratory syndrome,
|
| 216 |
+
GSM8021314,MONDO:0005091,severe acute respiratory syndrome,
|
| 217 |
+
GSM8021315,MONDO:0005091,severe acute respiratory syndrome,
|
| 218 |
+
GSM8021316,MONDO:0005091,severe acute respiratory syndrome,
|
| 219 |
+
GSM8021317,MONDO:0005091,severe acute respiratory syndrome,
|
| 220 |
+
GSM8021318,MONDO:0005087,respiratory system disorder,
|
| 221 |
+
GSM8021319,MONDO:0005087,respiratory system disorder,
|
| 222 |
+
GSM8021320,MONDO:0005087,respiratory system disorder,
|
| 223 |
+
GSM8021320,MONDO:0020683,acute disease,
|
| 224 |
+
GSM8021321,MONDO:0005091,severe acute respiratory syndrome,
|
| 225 |
+
GSM8021322,MONDO:0005091,severe acute respiratory syndrome,
|
| 226 |
+
GSM8021323,MONDO:0005091,severe acute respiratory syndrome,
|
| 227 |
+
GSM8021324,MONDO:0005091,severe acute respiratory syndrome,
|
| 228 |
+
GSM8021325,MONDO:0005091,severe acute respiratory syndrome,
|
| 229 |
+
GSM8021326,MONDO:0005091,severe acute respiratory syndrome,
|
| 230 |
+
GSM8021327,MONDO:0005091,severe acute respiratory syndrome,
|
| 231 |
+
GSM8021328,MONDO:0005087,respiratory system disorder,
|
| 232 |
+
GSM8021329,MONDO:0005087,respiratory system disorder,
|
| 233 |
+
GSM8021329,MONDO:0020683,acute disease,
|
| 234 |
+
GSM8021330,MONDO:0005091,severe acute respiratory syndrome,
|
| 235 |
+
GSM8021331,MONDO:0005091,severe acute respiratory syndrome,
|
| 236 |
+
GSM8021332,MONDO:0005091,severe acute respiratory syndrome,
|
| 237 |
+
GSM8021333,MONDO:0005091,severe acute respiratory syndrome,
|
| 238 |
+
GSM8021334,MONDO:0005091,severe acute respiratory syndrome,
|
| 239 |
+
GSM8021335,MONDO:0005091,severe acute respiratory syndrome,
|
| 240 |
+
GSM8021336,MONDO:0005091,severe acute respiratory syndrome,
|
| 241 |
+
GSM8021337,MONDO:0005091,severe acute respiratory syndrome,
|
| 242 |
+
GSM8021338,MONDO:0005091,severe acute respiratory syndrome,
|
| 243 |
+
GSM8021339,MONDO:0005091,severe acute respiratory syndrome,
|
| 244 |
+
GSM8021340,MONDO:0005091,severe acute respiratory syndrome,
|
| 245 |
+
GSM8021341,MONDO:0005091,severe acute respiratory syndrome,
|
| 246 |
+
GSM8021342,MONDO:0005091,severe acute respiratory syndrome,
|
| 247 |
+
GSM8021343,MONDO:0005091,severe acute respiratory syndrome,
|
| 248 |
+
GSM8021344,MONDO:0005091,severe acute respiratory syndrome,
|
| 249 |
+
GSM8021345,MONDO:0005091,severe acute respiratory syndrome,
|
| 250 |
+
GSM8021346,MONDO:0005091,severe acute respiratory syndrome,
|
| 251 |
+
GSM8021347,MONDO:0005091,severe acute respiratory syndrome,
|
| 252 |
+
GSM8021348,MONDO:0005091,severe acute respiratory syndrome,
|
| 253 |
+
GSM8021349,MONDO:0005091,severe acute respiratory syndrome,
|
| 254 |
+
GSM8021350,MONDO:0005091,severe acute respiratory syndrome,
|
| 255 |
+
GSM8021351,MONDO:0005091,severe acute respiratory syndrome,
|
| 256 |
+
GSM8021352,MONDO:0005091,severe acute respiratory syndrome,
|
| 257 |
+
GSM8021353,MONDO:0005091,severe acute respiratory syndrome,
|
| 258 |
+
GSM8199179,MONDO:0015547,hereditary dementia,
|
| 259 |
+
GSM8199179,MONDO:0024237,inherited neurodegenerative disorder,
|
| 260 |
+
GSM8199180,MONDO:0015547,hereditary dementia,
|
| 261 |
+
GSM8199180,MONDO:0024237,inherited neurodegenerative disorder,
|
| 262 |
+
GSM8199188,MONDO:0100087,familial Alzheimer disease,
|
| 263 |
+
GSM8199189,MONDO:0011743,Alzheimer disease 4,
|
| 264 |
+
GSM8200276,MONDO:0006412,sinus histiocytosis with massive lymphadenopathy,
|
| 265 |
+
GSM8329293,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 266 |
+
GSM8329294,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 267 |
+
GSM8329295,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 268 |
+
GSM8329296,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 269 |
+
GSM8329297,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 270 |
+
GSM8329298,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 271 |
+
GSM8367225,MONDO:0000429,autosomal genetic disease,
|
| 272 |
+
GSM8367226,MONDO:0000429,autosomal genetic disease,
|
| 273 |
+
GSM8367227,MONDO:0000429,autosomal genetic disease,
|
| 274 |
+
GSM8367228,MONDO:0000429,autosomal genetic disease,
|
| 275 |
+
GSM8367229,MONDO:0000429,autosomal genetic disease,
|
| 276 |
+
GSM8471250,MONDO:0003847,hereditary disease,
|
| 277 |
+
GSM8471252,MONDO:0003847,hereditary disease,
|
| 278 |
+
GSM8634986,MONDO:0011655,alveolar soft part sarcoma,
|
| 279 |
+
GSM8634987,MONDO:0011655,alveolar soft part sarcoma,
|
| 280 |
+
GSM8634988,MONDO:0011655,alveolar soft part sarcoma,
|
| 281 |
+
GSM8634989,MONDO:0011655,alveolar soft part sarcoma,
|
| 282 |
+
GSM8714493,MONDO:0100594,chronic idiopathic axonal polyneuropathy,
|
| 283 |
+
GSM8714495,MONDO:0100594,chronic idiopathic axonal polyneuropathy,
|
| 284 |
+
GSM8797488,MONDO:0005549,renal cell adenocarcinoma,
|
| 285 |
+
GSM8840046,MONDO:0016710,medulloblastoma with extensive nodularity,
|
| 286 |
+
GSM8840047,MONDO:0016710,medulloblastoma with extensive nodularity,
|
| 287 |
+
GSM8840048,MONDO:0016710,medulloblastoma with extensive nodularity,
|
| 288 |
+
GSM8840049,MONDO:0016710,medulloblastoma with extensive nodularity,
|
| 289 |
+
GSM8898655,MONDO:0011743,Alzheimer disease 4,
|
| 290 |
+
GSM8973624,MONDO:0100533,"hemorrhage, intracerebral, susceptibility to",
|
| 291 |
+
GSM8973625,MONDO:0100533,"hemorrhage, intracerebral, susceptibility to",
|
| 292 |
+
GSM8983044,MONDO:0005093,skin disorder,
|
| 293 |
+
GSM9002278,MONDO:1060125,congenital high airway obstruction syndrome,
|
| 294 |
+
GSM9002295,MONDO:1060125,congenital high airway obstruction syndrome,
|
| 295 |
+
GSM9040999,MONDO:0005096,squamous cell carcinoma,
|
| 296 |
+
GSM9052535,MONDO:0005091,severe acute respiratory syndrome,
|
| 297 |
+
GSM9052536,MONDO:0005091,severe acute respiratory syndrome,
|
| 298 |
+
GSM9052537,MONDO:0005091,severe acute respiratory syndrome,
|
| 299 |
+
GSM9052538,MONDO:0005091,severe acute respiratory syndrome,
|
| 300 |
+
GSM9052539,MONDO:0005091,severe acute respiratory syndrome,
|
| 301 |
+
GSM9052540,MONDO:0005091,severe acute respiratory syndrome,
|
| 302 |
+
GSM9052542,MONDO:0005091,severe acute respiratory syndrome,
|
| 303 |
+
GSM9071195,MONDO:0100313,focal segmental glomerulosclerosis,
|
| 304 |
+
GSM9098123,MONDO:0100073,methicillin-resistant staphylococcus aureus infectious disease,
|
| 305 |
+
GSM9098124,MONDO:0100073,methicillin-resistant staphylococcus aureus infectious disease,
|
| 306 |
+
GSM9197415,MONDO:0002251,hepatitis,
|
| 307 |
+
GSM9204000,MONDO:0015974,severe combined immunodeficiency,
|
| 308 |
+
GSM9204001,MONDO:0015974,severe combined immunodeficiency,
|
| 309 |
+
GSM9225693,MONDO:0005093,skin disorder,
|
| 310 |
+
GSM9228906,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 311 |
+
GSM9228907,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 312 |
+
GSM9239733,MONDO:0017604,marginal zone lymphoma,
|
| 313 |
+
GSM9424602,MONDO:0008963,Chediak-Higashi syndrome,
|
| 314 |
+
GSM9424603,MONDO:0008963,Chediak-Higashi syndrome,
|
| 315 |
+
GSM9424604,MONDO:0008963,Chediak-Higashi syndrome,
|
| 316 |
+
GSM9424605,MONDO:0008963,Chediak-Higashi syndrome,
|
| 317 |
+
GSM9424606,MONDO:0008963,Chediak-Higashi syndrome,
|
| 318 |
+
GSM9424607,MONDO:0008963,Chediak-Higashi syndrome,
|
| 319 |
+
GSM9424608,MONDO:0008963,Chediak-Higashi syndrome,
|
| 320 |
+
GSM9424608,MONDO:0100094,cannabinoid hyperemesis syndrome,
|
| 321 |
+
GSM9424609,MONDO:0008963,Chediak-Higashi syndrome,
|
| 322 |
+
GSM9424609,MONDO:0100094,cannabinoid hyperemesis syndrome,
|
| 323 |
+
GSM9424610,MONDO:0008963,Chediak-Higashi syndrome,
|
| 324 |
+
GSM9424611,MONDO:0008963,Chediak-Higashi syndrome,
|
| 325 |
+
GSM9424612,MONDO:0008963,Chediak-Higashi syndrome,
|
| 326 |
+
GSM9424613,MONDO:0008963,Chediak-Higashi syndrome,
|
| 327 |
+
GSM9424614,MONDO:0008963,Chediak-Higashi syndrome,
|
| 328 |
+
GSM9424615,MONDO:0008963,Chediak-Higashi syndrome,
|
| 329 |
+
GSM9424616,MONDO:0008963,Chediak-Higashi syndrome,
|
| 330 |
+
GSM9424616,MONDO:0100094,cannabinoid hyperemesis syndrome,
|
| 331 |
+
GSM9424617,MONDO:0008963,Chediak-Higashi syndrome,
|
| 332 |
+
GSM9424617,MONDO:0100094,cannabinoid hyperemesis syndrome,
|
| 333 |
+
GSM9424619,MONDO:0008963,Chediak-Higashi syndrome,
|
| 334 |
+
GSM9439741,MONDO:1010089,hypomyopathic dermatomyositis,
|
| 335 |
+
GSM9439749,MONDO:1010089,hypomyopathic dermatomyositis,
|
| 336 |
+
GSM9439752,MONDO:1010089,hypomyopathic dermatomyositis,
|
| 337 |
+
GSM9610990,MONDO:0011655,alveolar soft part sarcoma,
|
| 338 |
+
GSM9610991,MONDO:0011655,alveolar soft part sarcoma,
|
| 339 |
+
GSM10001168,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 340 |
+
GSM10001169,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 341 |
+
GSM10001170,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 342 |
+
GSM10001171,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 343 |
+
GSM10001172,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 344 |
+
GSM10001173,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 345 |
+
GSM10001174,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 346 |
+
GSM10001175,MONDO:1013329,"plasma cell myeloma, non-human animal",non-human-animal term on a human sample
|
| 347 |
+
GSM10039417,MONDO:0005091,severe acute respiratory syndrome,
|
| 348 |
+
GSM10039418,MONDO:0005091,severe acute respiratory syndrome,
|
metadata/v2/provenance.json
CHANGED
|
@@ -1,6 +1,6 @@
|
|
| 1 |
{
|
| 2 |
"schema": "sda-sample-metadata-2",
|
| 3 |
-
"built": "2026-11-
|
| 4 |
"base_release": "sda-unified-20261010-v3",
|
| 5 |
"base_hf_tag": "v1.0.0-20261025",
|
| 6 |
"base_hf_revision": "999566bf516169ba8c9cf1ad9e5a2b722bb8a97a",
|
|
@@ -24,7 +24,7 @@
|
|
| 24 |
"life_stage": 1.7,
|
| 25 |
"disease": 3.0
|
| 26 |
},
|
| 27 |
-
"human_review": "200-sample pack
|
| 28 |
},
|
| 29 |
"crosscheck_regex_organ_map": {
|
| 30 |
"organ_both_assigned": 10960,
|
|
@@ -53,16 +53,16 @@
|
|
| 53 |
"tumour_regex_only_after_xenograft": 43
|
| 54 |
},
|
| 55 |
"files": {
|
| 56 |
-
"README.md": "
|
| 57 |
-
"changes_v2.csv": "
|
| 58 |
-
"dropped_disease_terms.csv": "
|
| 59 |
-
"qa_v2.json": "
|
| 60 |
-
"samples_metadata_v2.csv": "
|
| 61 |
-
"samples_metadata_v2.parquet": "
|
| 62 |
-
"schema_v2.json": "
|
| 63 |
-
"studies_v2.csv": "
|
| 64 |
},
|
| 65 |
-
"version": "2.
|
| 66 |
"changes_from_2.0": "one name per assay (ASSAY_CANON, 261 rows); assay_type of 6 ISS (Cartana) samples (GSE227046) now imaging-based; um_per_unit and image_um_per_px copied exactly from the release parquet; organ, tissue, disease, life stage and other annotations unchanged",
|
| 67 |
"sensitivity_balanced_r2_series_units": {
|
| 68 |
"human": {
|
|
@@ -81,5 +81,6 @@
|
|
| 81 |
0.179
|
| 82 |
]
|
| 83 |
}
|
| 84 |
-
}
|
|
|
|
| 85 |
}
|
|
|
|
| 1 |
{
|
| 2 |
"schema": "sda-sample-metadata-2",
|
| 3 |
+
"built": "2026-11-06",
|
| 4 |
"base_release": "sda-unified-20261010-v3",
|
| 5 |
"base_hf_tag": "v1.0.0-20261025",
|
| 6 |
"base_hf_revision": "999566bf516169ba8c9cf1ad9e5a2b722bb8a97a",
|
|
|
|
| 24 |
"life_stage": 1.7,
|
| 25 |
"disease": 3.0
|
| 26 |
},
|
| 27 |
+
"human_review": "200-sample pack (100 random, 100 targeted) read by a human reviewer offline; the errors found were corrected in 2.2; per-field accuracy from that review not yet computed"
|
| 28 |
},
|
| 29 |
"crosscheck_regex_organ_map": {
|
| 30 |
"organ_both_assigned": 10960,
|
|
|
|
| 53 |
"tumour_regex_only_after_xenograft": 43
|
| 54 |
},
|
| 55 |
"files": {
|
| 56 |
+
"README.md": "4697dfa2e1310f62c930f950103766bc015610b3404895a8e6676fa6f017fe02",
|
| 57 |
+
"changes_v2.csv": "9f096e905effabc808c1b5ac142ff8cab3d9a367774ae82757b7406d23e631dc",
|
| 58 |
+
"dropped_disease_terms.csv": "28412ef3f7f7660ea7a85ed46ebcfecec08728dadc549e03510d31a2cce11b80",
|
| 59 |
+
"qa_v2.json": "eed9e5ea45d33345cf16772c07e7f0adbe472b2a55d800701cdaa63402f5f4c3",
|
| 60 |
+
"samples_metadata_v2.csv": "6d2ef49baa470140d3ae5fcc621192d2422bfbca715de217efae29181fbc1804",
|
| 61 |
+
"samples_metadata_v2.parquet": "690bcd2be263396e2ce9522c543a7353915f583e56aef31a1ad0b1f2c78226b1",
|
| 62 |
+
"schema_v2.json": "df7f767bbb2914a23d9295bdc0ba4dec4fca952465e1ec3138460728db57ecbe",
|
| 63 |
+
"studies_v2.csv": "47ae0513a19ebaea9282d8362164b5b898cd143ad7132310cba4d78ee5bb8150"
|
| 64 |
},
|
| 65 |
+
"version": "2.2",
|
| 66 |
"changes_from_2.0": "one name per assay (ASSAY_CANON, 261 rows); assay_type of 6 ISS (Cartana) samples (GSE227046) now imaging-based; um_per_unit and image_um_per_px copied exactly from the release parquet; organ, tissue, disease, life stage and other annotations unchanged",
|
| 67 |
"sensitivity_balanced_r2_series_units": {
|
| 68 |
"human": {
|
|
|
|
| 81 |
0.179
|
| 82 |
]
|
| 83 |
}
|
| 84 |
+
},
|
| 85 |
+
"changes_from_2.1": "rules: non-human-animal MONDO terms removed from human samples (16); culture/organoid/engineered life stage = not stated; sex from male/female words in sample text (77); rodent day ages in age series; manual corrections in 10 samples (overrides_v2.csv); new column sex_source"
|
| 86 |
}
|
metadata/v2/qa_v2.json
CHANGED
|
@@ -4,22 +4,24 @@
|
|
| 4 |
"flags": {
|
| 5 |
"low_confidence_annotation": 3119,
|
| 6 |
"feature_species_differs": 47,
|
| 7 |
-
"normal_but_disease_text":
|
| 8 |
},
|
| 9 |
-
"changes_vs_v3":
|
| 10 |
-
"dropped_short_synonym_disease_terms":
|
| 11 |
"life_stage_source": {
|
| 12 |
-
"luna":
|
| 13 |
"age rule: age with unit": 1630,
|
| 14 |
-
"age rule: bare number read as years":
|
| 15 |
"age rule: postnatal day": 404,
|
|
|
|
| 16 |
"age rule: embryonic day": 154,
|
| 17 |
"age rule: age in years": 113,
|
| 18 |
"age rule: post-conception / gestational weeks": 64,
|
|
|
|
| 19 |
"age rule: Carnegie stage": 4,
|
| 20 |
"age rule: age range midpoint": 4
|
| 21 |
},
|
| 22 |
-
"life_stage_rule_vs_luna_disagree":
|
| 23 |
"organ": {
|
| 24 |
"brain": 3391,
|
| 25 |
"colon": 1000,
|
|
@@ -29,7 +31,7 @@
|
|
| 29 |
"kidney": 590,
|
| 30 |
"skin": 489,
|
| 31 |
"pancreas": 488,
|
| 32 |
-
"other":
|
| 33 |
"heart": 292,
|
| 34 |
"breast": 267,
|
| 35 |
"small intestine": 251,
|
|
@@ -45,7 +47,7 @@
|
|
| 45 |
"uterus": 117,
|
| 46 |
"spleen": 108,
|
| 47 |
"bone": 107,
|
| 48 |
-
"prostate":
|
| 49 |
"placenta": 94,
|
| 50 |
"embryo (whole)": 93,
|
| 51 |
"eye": 89,
|
|
@@ -77,25 +79,25 @@
|
|
| 77 |
"unknown": 2
|
| 78 |
},
|
| 79 |
"disease_status": {
|
| 80 |
-
"disease":
|
| 81 |
-
"normal":
|
| 82 |
"perturbation": 1125,
|
| 83 |
"not stated": 67
|
| 84 |
},
|
| 85 |
"life_stage": {
|
| 86 |
-
"not stated":
|
| 87 |
-
"adult":
|
| 88 |
"aged": 1182,
|
| 89 |
"juvenile": 330,
|
| 90 |
-
"neonatal or infant":
|
| 91 |
"embryonic": 282,
|
| 92 |
-
"fetal":
|
| 93 |
},
|
| 94 |
"sex": {
|
| 95 |
-
"unknown":
|
| 96 |
-
"male":
|
| 97 |
-
"female":
|
| 98 |
-
"mixed":
|
| 99 |
},
|
| 100 |
"preservation": {
|
| 101 |
"null": 6957,
|
|
@@ -103,8 +105,8 @@
|
|
| 103 |
"fresh frozen": 2327,
|
| 104 |
"fixed frozen": 40
|
| 105 |
},
|
| 106 |
-
"with_tissue_term":
|
| 107 |
-
"with_disease_term":
|
| 108 |
"with_pubmed": 8479,
|
| 109 |
"with_donor_key": 3391
|
| 110 |
}
|
|
|
|
| 4 |
"flags": {
|
| 5 |
"low_confidence_annotation": 3119,
|
| 6 |
"feature_species_differs": 47,
|
| 7 |
+
"normal_but_disease_text": 17
|
| 8 |
},
|
| 9 |
+
"changes_vs_v3": 236,
|
| 10 |
+
"dropped_short_synonym_disease_terms": 347,
|
| 11 |
"life_stage_source": {
|
| 12 |
+
"luna": 8172,
|
| 13 |
"age rule: age with unit": 1630,
|
| 14 |
+
"age rule: bare number read as years": 1351,
|
| 15 |
"age rule: postnatal day": 404,
|
| 16 |
+
"rule: culture or organoid (culture time is not a life stage)": 239,
|
| 17 |
"age rule: embryonic day": 154,
|
| 18 |
"age rule: age in years": 113,
|
| 19 |
"age rule: post-conception / gestational weeks": 64,
|
| 20 |
+
"age rule: days in an age series": 28,
|
| 21 |
"age rule: Carnegie stage": 4,
|
| 22 |
"age rule: age range midpoint": 4
|
| 23 |
},
|
| 24 |
+
"life_stage_rule_vs_luna_disagree": 624,
|
| 25 |
"organ": {
|
| 26 |
"brain": 3391,
|
| 27 |
"colon": 1000,
|
|
|
|
| 31 |
"kidney": 590,
|
| 32 |
"skin": 489,
|
| 33 |
"pancreas": 488,
|
| 34 |
+
"other": 400,
|
| 35 |
"heart": 292,
|
| 36 |
"breast": 267,
|
| 37 |
"small intestine": 251,
|
|
|
|
| 47 |
"uterus": 117,
|
| 48 |
"spleen": 108,
|
| 49 |
"bone": 107,
|
| 50 |
+
"prostate": 101,
|
| 51 |
"placenta": 94,
|
| 52 |
"embryo (whole)": 93,
|
| 53 |
"eye": 89,
|
|
|
|
| 79 |
"unknown": 2
|
| 80 |
},
|
| 81 |
"disease_status": {
|
| 82 |
+
"disease": 7023,
|
| 83 |
+
"normal": 3948,
|
| 84 |
"perturbation": 1125,
|
| 85 |
"not stated": 67
|
| 86 |
},
|
| 87 |
"life_stage": {
|
| 88 |
+
"not stated": 7060,
|
| 89 |
+
"adult": 2838,
|
| 90 |
"aged": 1182,
|
| 91 |
"juvenile": 330,
|
| 92 |
+
"neonatal or infant": 324,
|
| 93 |
"embryonic": 282,
|
| 94 |
+
"fetal": 147
|
| 95 |
},
|
| 96 |
"sex": {
|
| 97 |
+
"unknown": 7441,
|
| 98 |
+
"male": 2689,
|
| 99 |
+
"female": 2012,
|
| 100 |
+
"mixed": 21
|
| 101 |
},
|
| 102 |
"preservation": {
|
| 103 |
"null": 6957,
|
|
|
|
| 105 |
"fresh frozen": 2327,
|
| 106 |
"fixed frozen": 40
|
| 107 |
},
|
| 108 |
+
"with_tissue_term": 11605,
|
| 109 |
+
"with_disease_term": 6479,
|
| 110 |
"with_pubmed": 8479,
|
| 111 |
"with_donor_key": 3391
|
| 112 |
}
|
metadata/v2/samples_metadata_v2.csv
CHANGED
|
The diff for this file is too large to render.
See raw diff
|
|
|
metadata/v2/samples_metadata_v2.parquet
CHANGED
|
@@ -1,3 +1,3 @@
|
|
| 1 |
version https://git-lfs.github.com/spec/v1
|
| 2 |
-
oid sha256:
|
| 3 |
-
size
|
|
|
|
| 1 |
version https://git-lfs.github.com/spec/v1
|
| 2 |
+
oid sha256:690bcd2be263396e2ce9522c543a7353915f583e56aef31a1ad0b1f2c78226b1
|
| 3 |
+
size 822563
|
metadata/v2/schema_v2.json
CHANGED
|
@@ -34,6 +34,7 @@
|
|
| 34 |
"life_stage_luna": "Luna's life-stage answer (kept when the age rule overrides it)",
|
| 35 |
"age_raw": "age as written",
|
| 36 |
"sex": "male / female / mixed / unknown (coded values without a stated key, e.g. 1/2, stay unknown)",
|
|
|
|
| 37 |
"sex_raw": "sex as written",
|
| 38 |
"donor_key": "<published_gse>:<donor id>; donor IDs are only unique within a study",
|
| 39 |
"donor_id_raw": "donor ID as written",
|
|
|
|
| 34 |
"life_stage_luna": "Luna's life-stage answer (kept when the age rule overrides it)",
|
| 35 |
"age_raw": "age as written",
|
| 36 |
"sex": "male / female / mixed / unknown (coded values without a stated key, e.g. 1/2, stay unknown)",
|
| 37 |
+
"sex_source": "extracted field, sample text (the words male / female in title, source or characteristics), manual, or not stated",
|
| 38 |
"sex_raw": "sex as written",
|
| 39 |
"donor_key": "<published_gse>:<donor id>; donor IDs are only unique within a study",
|
| 40 |
"donor_id_raw": "donor ID as written",
|
metadata/v2/studies_v2.csv
CHANGED
|
@@ -629,7 +629,7 @@ GSE283832,"A cycling, progenitor-like cell population at the root of atypical te
|
|
| 629 |
GSE283863,Cranial radiotherapy profoundly affects glia without inducing widespread cellular senescence,1,Mus musculus,CosMx,CosMx,brain,,perturbation,0,40518745,train
|
| 630 |
GSE283872,Prior High Fiber Intake Impinges on the Cellular Responses of Mesenteric Adipose and Intestinal Tissues to Subsequent High Fat Feeding [Spatial Transcriptomics],4,Mus musculus,Stereo-seq,Stereo-seq,small intestine,,perturbation,0,41520334,test
|
| 631 |
GSE283883,Spatial Transcriptomics Sequencing of Mouse Liver at 2µm Resolution Using a Novel Spatial DNA Chip,1,Mus musculus,Other,"other (named in GEO, not in list)",liver,,normal,0,,train
|
| 632 |
-
GSE283945,Spatially Resolved Insights Into Fistulating Crohn’s Disease Pathogenesis - Visium Spatial Transcriptomics,35,Homo sapiens,Visium,Visium,colon;small intestine;rectum;other,Crohn disease;inflammatory bowel disease;intestinal disorder,disease;normal,35,41224999,test
|
| 633 |
GSE283959,Spatially resolved chimeric analysis reveals extracellular CKB-mediated ATP uptake at the glioma-astrocyte invasive front,4,Mus musculus,Visium,Visium,brain,glioblastoma;glioma,disease,4,40991701,train
|
| 634 |
GSE283967,Multi-modal refinement of the human heart atlas during the first gestational trimester,3,Homo sapiens,Visium,Visium,heart,,normal,3,39927812,train
|
| 635 |
GSE284005,A single-cell resolution spatial transcriptomics atlas of human multiple sclerosis lesion (MERSCOPE),17,Homo sapiens,MERFISH/MERSCOPE,MERFISH,brain,multiple sclerosis,disease;normal,0,,train
|
|
@@ -753,7 +753,7 @@ GSE294669,Spatial Proteomics and Transcriptomics Reveal Early Immune Cell Organi
|
|
| 753 |
GSE294759,Application of spatial transcriptomics across organoids for a high-resolution spatial whole-transcriptome benchmarking dataset,9,Mus musculus;Homo sapiens,Stereo-seq,Stereo-seq,head and neck;heart;brain;cartilage;lung;other;kidney,,normal,0,42164865,train
|
| 754 |
GSE294765,A skeletal muscle atlas shows neuromuscular junction adaptations to growth and atrophy,6,Mus musculus,Visium,Visium,skeletal muscle,,perturbation;normal,6,42019489,train
|
| 755 |
GSE294814,Spatially resolved profiling of host and bacteria RNAs in mammalian tissue,7,Mus musculus,DBiT-seq,microDBiT,colon;small intestine,,normal,0,,val
|
| 756 |
-
GSE294844,Transcriptional signature for dysplastic epidermal development in human pre-malignant skin,5,Homo sapiens,Visium,Visium CytAssist;Visium,skin,,
|
| 757 |
GSE294965,Spatio-temporal interaction of immune and renal cells determines glomerular crescent formation in autoimmune kidney disease,9,Homo sapiens,Xenium,Xenium,kidney,kidney disorder,disease,9,40393992,train
|
| 758 |
GSE295043,A spatiotemporal atlas of orchiectomy-induced modulation of cellular composition and gene expression in the mouse prostate,8,Mus musculus,Visium,Visium,prostate,,perturbation,8,40974890,train
|
| 759 |
GSE295060,Gain-of-function PPM1D mutations attenuate ischemic stroke,2,Mus musculus,Visium,Visium,brain,cerebral artery occlusion;ischemic stroke,disease,2,,train
|
|
@@ -792,7 +792,7 @@ GSE296896,High-resolution spatial transcriptomics of mouse intestine [Spatial-RN
|
|
| 792 |
GSE296897,High-resolution spatial transcriptomics of DARLIN mouse [CRISPR array amplicon],36,Mus musculus,BMK S1000,BMKMANU S1000/S3000,small intestine;colon;brain,,perturbation,0,42373956,train
|
| 793 |
GSE296975,Defining Cellular Diversity at the Swine Maternal-Fetal Interface Using Spatial Transcriptomics and Organoids [MFI017_Visium],4,Sus scrofa,Visium,Visium,placenta,,normal,4,40875599,train
|
| 794 |
GSE296982,Single cell map of the adult female mouse urethra reveals epithelial and stromal macrophages with distinct functional identities,1,Mus musculus,Xenium,Xenium,other,,normal,1,40907791,train
|
| 795 |
-
GSE297058,Hereditary Chronic Pancreatitis Induced Plasticity Cooperates with Mutant Kras in Early Pancreatic Carcinogenesis,2,Mus musculus,Visium HD,Visium HD,pancreas,
|
| 796 |
GSE297064,Targeting circulating mechanoresponsive monocytes and macrophages to reduce fibrosis,2,Homo sapiens,Visium,Visium,skin,,not stated;disease,2,41120571,train
|
| 797 |
GSE297068,A spatial code governs olfactory receptor choice and aligns sensory maps in the nose and brain,6,Mus musculus,MERFISH/MERSCOPE;Stereo-seq,MERSCOPE;Stereo-seq,head and neck,,normal,0,42054991,train
|
| 798 |
GSE297081,Inhibition of ACLY enhances tumor immunogenicity and resolves MASH-driven HCC,4,Mus musculus,Visium,Visium,liver,metabolic dysfunction-associated steatohepatitis;hepatocellular carcinoma,disease;normal,4,40739358,test
|
|
@@ -932,7 +932,7 @@ GSE307504,Single-cell and spatial transcriptomic atlas of pathological scars unc
|
|
| 932 |
GSE307534,"Spatial transcriptomics analysis of normal lung tissues, precursor lung lesions and invasive lung adenocarcinomas",56,Homo sapiens,Visium,Visium,lung,glandular cell neoplasm;lung adenocarcinoma,disease;normal,56,41202811,train
|
| 933 |
GSE307586,Spatiomolecular mapping reveals anatomical organization of heterogeneous cell types in the human nucleus accumbens [Spatial Transcriptomics],38,Homo sapiens,Visium,Visium,brain,,normal,38,40964296;42385698,train
|
| 934 |
GSE307588,Spatial profiling of hypoxic injury in human kidney organoids,25,Homo sapiens,Xenium,Xenium,kidney,,perturbation;normal;disease,0,42613631,train
|
| 935 |
-
GSE307661,Belantamab Mafodotin Triggers Immune Invigoration in Multiple Myeloma Via Inflammatory and Immunogenic Cell Death [Xenium],3,Homo sapiens,Xenium,Xenium,bone marrow,
|
| 936 |
GSE307719,Cellular and molecular signatures of the vascular microenvironment define the pre-metastatic brain and meninges [MERFISH],8,Mus musculus,MERFISH/MERSCOPE,MERSCOPE,brain;meninges,neoplasm,normal;disease,0,,train
|
| 937 |
GSE307744,Human bladder Visium spatial gene expression,1,Homo sapiens,Visium,Visium,bladder,,not stated,1,,train
|
| 938 |
GSE307817,A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease,12,Homo sapiens,Visium,Visium,kidney,diabetic kidney disease;diabetes mellitus;chronic kidney disease;kidney disorder;glucose metabolism disease,disease,12,42055320,train
|
|
@@ -1033,7 +1033,7 @@ GSE315411,Fishing with Two Lines: A Hybrid Approach to Spatial Transcriptomic Di
|
|
| 1033 |
GSE315416,A High-Resolution Stereo-seq Spatial Transcriptomic Dataset of the Bovine Liver,2,Bos taurus,Stereo-seq,Stereo-seq,liver,,normal,0,42737743,train
|
| 1034 |
GSE315435,Rhythmic nephron formation in the developing kidney,11,Mus musculus;Homo sapiens,Xenium,Xenium,kidney,,normal,11,,train
|
| 1035 |
GSE315482,Single-Cell Multi-omics Profiling of Mouse Hepatic Immune Microenvironment Reveals Neutrophil-Kupffer Cell Crosstalk via Thrombospondin-1/CD36 after Surgical Stress,4,Mus musculus,Visium,Visium,liver,ischemia reperfusion injury,perturbation;disease,4,,train
|
| 1036 |
-
GSE315487,CD73 inhibition overcomes adaptive immune resistance to PARP inhibition in models of prostate cancer,4,Mus musculus,Visium,Visium,prostate,prostate cancer,disease,0,,train
|
| 1037 |
GSE315553,Spatial Transcriptomics Data from Human Choroid Plexus,4,Homo sapiens,Slide-seq,Slide-seq,brain,,normal;not stated,0,41648589,val
|
| 1038 |
GSE315907,p53 maintains healthy aging,196,Mus musculus,CosMx,CosMx,liver,,perturbation;normal,196,,train
|
| 1039 |
GSE316346,TGFβ1 and Oncostatin M promotes the organization of two distinct stromal niches controlling different EMT states [Xenium],2,Mus musculus,Xenium,Xenium,skin,mesenchymal cell neoplasm,disease,2,,train
|
|
@@ -1174,7 +1174,7 @@ GSE333244,Spatial Rewiring of Enterocyte Identity in Celiac Disease [Visium],4,H
|
|
| 1174 |
GSE333401,Prenatal DBP Exposure Dysregulate Fetal-Placenta Spatial Transcriptomic Profiles,13,Mus musculus,Visium,Visium,placenta,,perturbation,13,,val
|
| 1175 |
GSE333479,A unified spatial transcriptome profiling of ten mouse organs,21,Mus musculus,Stereo-seq,Stereo-seq,colon;brain;kidney;skin;thymus;spleen;lung;uterus;testis;ovary,,normal,0,42374103,train
|
| 1176 |
GSE333529,A skin–kidney neutrophil axis links UV exposure to renal angiogenesis and tissue remodeling in healthy and lupus kidneys. [Spatial Transcriptomics],4,Homo sapiens,Visium,Visium,kidney,systemic lupus erythematosus,disease,4,42679049,train
|
| 1177 |
-
GSE333617,Targeting JAK1/3-STAT1 signaling attenuates cytotoxic T lymphocytes activation for the treatment in Stevens-Johnson syndrome and toxic epidermal necrolysis,4,Homo sapiens,Visium,Visium,skin,Stevens-Johnson syndrome,disease,4,,train
|
| 1178 |
GSE333685,Vascular smooth muscle cell state trajectories mediate molecular mechanisms of coronary disease risk,1,Mus musculus,Xenium,Xenium,blood vessel,coronary artery disorder,disease,1,41844614,train
|
| 1179 |
GSE333693,Rat thymic epithelium-free areas are specialized medullary niches enriched for mature thymocytes and distinct stromal subsets,1,Rattus norvegicus,Stereo-seq,Stereo-seq,thymus,,normal,0,,train
|
| 1180 |
GSE333735,TGFbeta determines epithelial tissue spacing by regulating mesenchymal condensation,3,Gallus gallus,DBiT-seq,DBiT-seq,lung,,normal,0,42446999,train
|
|
@@ -1254,7 +1254,7 @@ GSE344692,Placental TRPV2 supports trophoblast function and normal fetal develop
|
|
| 1254 |
GSE344748,REM sleep readiness and duration are encoded during NREM by spinal-projecting sublaterodorsal (SLD) neurons.,4,Mus musculus,Slide-seq,Slide-seq,brain,,perturbation,0,,val
|
| 1255 |
GSE344969,Spatial transcriptomic profiling of calcified human coronary artery lesions,2,Homo sapiens,Visium,Visium,blood vessel,calcinosis,disease,2,,train
|
| 1256 |
GSE345289,Gene expression mapping of eye after adipocyte depletion,2,Mus musculus,Xenium,Xenium,eye,,perturbation,2,,val
|
| 1257 |
-
GSE345302,Spatial profiling identifies a distinct and topographically-defined tumor microenvironment that emerges during multiple myeloma evolution,8,Homo sapiens,Xenium,Xenium,bone marrow,
|
| 1258 |
GSE345359,A single-nucleus and spatial transcriptomic atlas of the Syrian hamster preoptic area across hibernation states,4,Mesocricetus auratus,Xenium,Xenium,brain,,normal,1,,train
|
| 1259 |
GSE345643,Human Adult and Pediatric Multimodal Transcriptomic Atlas of Progression from Pressure-Loaded to Failing Right Ventricle [Xenium spatial transcriptomics],6,Homo sapiens,Xenium,Xenium,heart,,disease;normal,6,,test
|
| 1260 |
GSE345644,Human bladder cell spatial mapping [Xenium],1,Homo sapiens,Xenium,Xenium,bladder,,normal,1,,val
|
|
|
|
| 629 |
GSE283863,Cranial radiotherapy profoundly affects glia without inducing widespread cellular senescence,1,Mus musculus,CosMx,CosMx,brain,,perturbation,0,40518745,train
|
| 630 |
GSE283872,Prior High Fiber Intake Impinges on the Cellular Responses of Mesenteric Adipose and Intestinal Tissues to Subsequent High Fat Feeding [Spatial Transcriptomics],4,Mus musculus,Stereo-seq,Stereo-seq,small intestine,,perturbation,0,41520334,test
|
| 631 |
GSE283883,Spatial Transcriptomics Sequencing of Mouse Liver at 2µm Resolution Using a Novel Spatial DNA Chip,1,Mus musculus,Other,"other (named in GEO, not in list)",liver,,normal,0,,train
|
| 632 |
+
GSE283945,Spatially Resolved Insights Into Fistulating Crohn’s Disease Pathogenesis - Visium Spatial Transcriptomics,35,Homo sapiens,Visium,Visium,colon;small intestine;rectum;other,Crohn disease;inflammatory bowel disease;intestinal disorder;diverticulitis of colon,disease;normal,35,41224999,test
|
| 633 |
GSE283959,Spatially resolved chimeric analysis reveals extracellular CKB-mediated ATP uptake at the glioma-astrocyte invasive front,4,Mus musculus,Visium,Visium,brain,glioblastoma;glioma,disease,4,40991701,train
|
| 634 |
GSE283967,Multi-modal refinement of the human heart atlas during the first gestational trimester,3,Homo sapiens,Visium,Visium,heart,,normal,3,39927812,train
|
| 635 |
GSE284005,A single-cell resolution spatial transcriptomics atlas of human multiple sclerosis lesion (MERSCOPE),17,Homo sapiens,MERFISH/MERSCOPE,MERFISH,brain,multiple sclerosis,disease;normal,0,,train
|
|
|
|
| 753 |
GSE294759,Application of spatial transcriptomics across organoids for a high-resolution spatial whole-transcriptome benchmarking dataset,9,Mus musculus;Homo sapiens,Stereo-seq,Stereo-seq,head and neck;heart;brain;cartilage;lung;other;kidney,,normal,0,42164865,train
|
| 754 |
GSE294765,A skeletal muscle atlas shows neuromuscular junction adaptations to growth and atrophy,6,Mus musculus,Visium,Visium,skeletal muscle,,perturbation;normal,6,42019489,train
|
| 755 |
GSE294814,Spatially resolved profiling of host and bacteria RNAs in mammalian tissue,7,Mus musculus,DBiT-seq,microDBiT,colon;small intestine,,normal,0,,val
|
| 756 |
+
GSE294844,Transcriptional signature for dysplastic epidermal development in human pre-malignant skin,5,Homo sapiens,Visium,Visium CytAssist;Visium,skin,actinic keratosis,disease,4,,test
|
| 757 |
GSE294965,Spatio-temporal interaction of immune and renal cells determines glomerular crescent formation in autoimmune kidney disease,9,Homo sapiens,Xenium,Xenium,kidney,kidney disorder,disease,9,40393992,train
|
| 758 |
GSE295043,A spatiotemporal atlas of orchiectomy-induced modulation of cellular composition and gene expression in the mouse prostate,8,Mus musculus,Visium,Visium,prostate,,perturbation,8,40974890,train
|
| 759 |
GSE295060,Gain-of-function PPM1D mutations attenuate ischemic stroke,2,Mus musculus,Visium,Visium,brain,cerebral artery occlusion;ischemic stroke,disease,2,,train
|
|
|
|
| 792 |
GSE296897,High-resolution spatial transcriptomics of DARLIN mouse [CRISPR array amplicon],36,Mus musculus,BMK S1000,BMKMANU S1000/S3000,small intestine;colon;brain,,perturbation,0,42373956,train
|
| 793 |
GSE296975,Defining Cellular Diversity at the Swine Maternal-Fetal Interface Using Spatial Transcriptomics and Organoids [MFI017_Visium],4,Sus scrofa,Visium,Visium,placenta,,normal,4,40875599,train
|
| 794 |
GSE296982,Single cell map of the adult female mouse urethra reveals epithelial and stromal macrophages with distinct functional identities,1,Mus musculus,Xenium,Xenium,other,,normal,1,40907791,train
|
| 795 |
+
GSE297058,Hereditary Chronic Pancreatitis Induced Plasticity Cooperates with Mutant Kras in Early Pancreatic Carcinogenesis,2,Mus musculus,Visium HD,Visium HD,pancreas,hereditary chronic pancreatitis,normal;disease,2,41419303,train
|
| 796 |
GSE297064,Targeting circulating mechanoresponsive monocytes and macrophages to reduce fibrosis,2,Homo sapiens,Visium,Visium,skin,,not stated;disease,2,41120571,train
|
| 797 |
GSE297068,A spatial code governs olfactory receptor choice and aligns sensory maps in the nose and brain,6,Mus musculus,MERFISH/MERSCOPE;Stereo-seq,MERSCOPE;Stereo-seq,head and neck,,normal,0,42054991,train
|
| 798 |
GSE297081,Inhibition of ACLY enhances tumor immunogenicity and resolves MASH-driven HCC,4,Mus musculus,Visium,Visium,liver,metabolic dysfunction-associated steatohepatitis;hepatocellular carcinoma,disease;normal,4,40739358,test
|
|
|
|
| 932 |
GSE307534,"Spatial transcriptomics analysis of normal lung tissues, precursor lung lesions and invasive lung adenocarcinomas",56,Homo sapiens,Visium,Visium,lung,glandular cell neoplasm;lung adenocarcinoma,disease;normal,56,41202811,train
|
| 933 |
GSE307586,Spatiomolecular mapping reveals anatomical organization of heterogeneous cell types in the human nucleus accumbens [Spatial Transcriptomics],38,Homo sapiens,Visium,Visium,brain,,normal,38,40964296;42385698,train
|
| 934 |
GSE307588,Spatial profiling of hypoxic injury in human kidney organoids,25,Homo sapiens,Xenium,Xenium,kidney,,perturbation;normal;disease,0,42613631,train
|
| 935 |
+
GSE307661,Belantamab Mafodotin Triggers Immune Invigoration in Multiple Myeloma Via Inflammatory and Immunogenic Cell Death [Xenium],3,Homo sapiens,Xenium,Xenium,bone marrow,plasma cell myeloma,disease,3,,test
|
| 936 |
GSE307719,Cellular and molecular signatures of the vascular microenvironment define the pre-metastatic brain and meninges [MERFISH],8,Mus musculus,MERFISH/MERSCOPE,MERSCOPE,brain;meninges,neoplasm,normal;disease,0,,train
|
| 937 |
GSE307744,Human bladder Visium spatial gene expression,1,Homo sapiens,Visium,Visium,bladder,,not stated,1,,train
|
| 938 |
GSE307817,A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease,12,Homo sapiens,Visium,Visium,kidney,diabetic kidney disease;diabetes mellitus;chronic kidney disease;kidney disorder;glucose metabolism disease,disease,12,42055320,train
|
|
|
|
| 1033 |
GSE315416,A High-Resolution Stereo-seq Spatial Transcriptomic Dataset of the Bovine Liver,2,Bos taurus,Stereo-seq,Stereo-seq,liver,,normal,0,42737743,train
|
| 1034 |
GSE315435,Rhythmic nephron formation in the developing kidney,11,Mus musculus;Homo sapiens,Xenium,Xenium,kidney,,normal,11,,train
|
| 1035 |
GSE315482,Single-Cell Multi-omics Profiling of Mouse Hepatic Immune Microenvironment Reveals Neutrophil-Kupffer Cell Crosstalk via Thrombospondin-1/CD36 after Surgical Stress,4,Mus musculus,Visium,Visium,liver,ischemia reperfusion injury,perturbation;disease,4,,train
|
| 1036 |
+
GSE315487,CD73 inhibition overcomes adaptive immune resistance to PARP inhibition in models of prostate cancer,4,Mus musculus,Visium,Visium,prostate;other,prostate cancer,disease,0,,train
|
| 1037 |
GSE315553,Spatial Transcriptomics Data from Human Choroid Plexus,4,Homo sapiens,Slide-seq,Slide-seq,brain,,normal;not stated,0,41648589,val
|
| 1038 |
GSE315907,p53 maintains healthy aging,196,Mus musculus,CosMx,CosMx,liver,,perturbation;normal,196,,train
|
| 1039 |
GSE316346,TGFβ1 and Oncostatin M promotes the organization of two distinct stromal niches controlling different EMT states [Xenium],2,Mus musculus,Xenium,Xenium,skin,mesenchymal cell neoplasm,disease,2,,train
|
|
|
|
| 1174 |
GSE333401,Prenatal DBP Exposure Dysregulate Fetal-Placenta Spatial Transcriptomic Profiles,13,Mus musculus,Visium,Visium,placenta,,perturbation,13,,val
|
| 1175 |
GSE333479,A unified spatial transcriptome profiling of ten mouse organs,21,Mus musculus,Stereo-seq,Stereo-seq,colon;brain;kidney;skin;thymus;spleen;lung;uterus;testis;ovary,,normal,0,42374103,train
|
| 1176 |
GSE333529,A skin–kidney neutrophil axis links UV exposure to renal angiogenesis and tissue remodeling in healthy and lupus kidneys. [Spatial Transcriptomics],4,Homo sapiens,Visium,Visium,kidney,systemic lupus erythematosus,disease,4,42679049,train
|
| 1177 |
+
GSE333617,Targeting JAK1/3-STAT1 signaling attenuates cytotoxic T lymphocytes activation for the treatment in Stevens-Johnson syndrome and toxic epidermal necrolysis,4,Homo sapiens,Visium,Visium,skin,Stevens-Johnson syndrome,disease;normal,4,,train
|
| 1178 |
GSE333685,Vascular smooth muscle cell state trajectories mediate molecular mechanisms of coronary disease risk,1,Mus musculus,Xenium,Xenium,blood vessel,coronary artery disorder,disease,1,41844614,train
|
| 1179 |
GSE333693,Rat thymic epithelium-free areas are specialized medullary niches enriched for mature thymocytes and distinct stromal subsets,1,Rattus norvegicus,Stereo-seq,Stereo-seq,thymus,,normal,0,,train
|
| 1180 |
GSE333735,TGFbeta determines epithelial tissue spacing by regulating mesenchymal condensation,3,Gallus gallus,DBiT-seq,DBiT-seq,lung,,normal,0,42446999,train
|
|
|
|
| 1254 |
GSE344748,REM sleep readiness and duration are encoded during NREM by spinal-projecting sublaterodorsal (SLD) neurons.,4,Mus musculus,Slide-seq,Slide-seq,brain,,perturbation,0,,val
|
| 1255 |
GSE344969,Spatial transcriptomic profiling of calcified human coronary artery lesions,2,Homo sapiens,Visium,Visium,blood vessel,calcinosis,disease,2,,train
|
| 1256 |
GSE345289,Gene expression mapping of eye after adipocyte depletion,2,Mus musculus,Xenium,Xenium,eye,,perturbation,2,,val
|
| 1257 |
+
GSE345302,Spatial profiling identifies a distinct and topographically-defined tumor microenvironment that emerges during multiple myeloma evolution,8,Homo sapiens,Xenium,Xenium,bone marrow,plasma cell myeloma,disease,8,42678098,train
|
| 1258 |
GSE345359,A single-nucleus and spatial transcriptomic atlas of the Syrian hamster preoptic area across hibernation states,4,Mesocricetus auratus,Xenium,Xenium,brain,,normal,1,,train
|
| 1259 |
GSE345643,Human Adult and Pediatric Multimodal Transcriptomic Atlas of Progression from Pressure-Loaded to Failing Right Ventricle [Xenium spatial transcriptomics],6,Homo sapiens,Xenium,Xenium,heart,,disease;normal,6,,test
|
| 1260 |
GSE345644,Human bladder cell spatial mapping [Xenium],1,Homo sapiens,Xenium,Xenium,bladder,,normal,1,,val
|